Monitoring Data Sufficiency -Appendix 1 for SEC-00028 

Performing internal and external dose reconstructions requires worker monitoring data. Worker 

monitoring data includes data from members of the proposed class as well as data from workers 

outside the proposed class who were performing jobs with higher exposure potentials. Using worker 

monitoring data provides a means of calculating claimant-favorable and maximum potential radiation 

doses for class members who were unmonitored or have gaps in their monitoring records. 

Calculating claimant-favorable and/or maximum potential radiation doses for unmonitored employees 

is only possible through sufficient data. Data sufficiency is determined through appropriate sampling, 

which involves choosing the correct monitoring locations and personnel with the highest exposure 

locations and activities, appropriate analytical techniques, and record keeping. In addition to sampling, 

analytical techniques, and record keeping, it is important to evaluate the exposure potential associated 

with activities that were non-production oriented, new, and/or short-lived, such as research and 

development activities. 

In addition to the sampling, analytical, and record keeping information, NIOSH also evaluated other 

documentation related to Y-12. Historical Y-12 documents include detailed information about 

monitoring devices, sampling techniques, and analytical methods. In addition to historical document 

resources, further information supporting the adequacy of monitoring devices, sampling techniques, 

and analytical methods is presented in the Y-12 Site Profile (ORAUT-TKBS-0014-2 Rev. 00; 

ORAUT-TKBS-0014-6, Rev. 00; ORAUT-TKBS-0014-1, Rev. 00; ORAUT-TKBS-0014-3, Rev. 00; 

ORAUT-TKBS-0014-5, Rev. 01-A) and in Historical Evaluation of the Film Badge Dosimetry 

Program at the Y-12 Facility in Oak Ridge, Tennessee: Part 1 and 2 (ORAU Technical Report 2004­

0888; ORAU Technical Report 2004-1406). The Y-12 Site Profile and in the Historical Evaluation of 

the Film Badge Dosimetry Program at the Y-12 Facility in Oak Ridge, Tennessee: Part 1 and 2 

includes information supporting the proposition that activities and personnel associated with the 

highest exposure potentials were regularly monitored. 

Documentation supports NIOSH findings that activities and personnel associated with the highest 

exposure potential were regularly monitored. However, given the importance of verifying coworker 

data sufficiency, NIOSH performed additional activities to verify data sufficiency; these additional 

activities focused on historical monitoring selection and data credibility and have been included in this 

evaluation. The additional data sufficiency verification activities included: 

•	 Retrieval and review of Health Physics Progress Reports and additional monitoring related 

documents 

•	 Interviews with plant workers employed during the subject timeframe 

•	 Credibility, validity, and representativeness of data 

•	 Statistical analysis of available personal monitoring data 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

This page intentionally blank 

2 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028
 

Table of Contents 

Monitoring Data Sufficiency -Appendix 1 for SEC-00028 .................................................................... 1
 

1.0 Y-12 Health Physics Progress Reports........................................................................................... 7
 

2.0 Y-12 Employee Interviews ............................................................................................................. 7
 

3.0 Credibility, Validity, and Representativeness of Data ................................................................... 8 

3.1 Pedigree of the Data .............................................................................................................. 9 

3.2 Methodology........................................................................................................................ 10 

3.3 Data Consistency ................................................................................................................. 10 

3.3.1 Reported Analysis Totals and General Data References......................................... 11 

3.3.2 Reported Urinalysis Results .................................................................................... 11 

3.3.3 Punch Cards Data Comparison................................................................................ 14 

3.3.4 External Monitoring Results.................................................................................... 14
 

4.0 Statistical Analysis of Monitoring Data ....................................................................................... 15 

4.1 Job Type Analysis of Y-12 Workers Selected for Regression Analysis ............................. 16 

4.1.1 Gamma-Dose Regression Groups ........................................................................... 16 

4.1.2 Beta-Dose Regression Groups................................................................................. 17 

4.2 Analysis Using Modified Boxplots ..................................................................................... 18 

4.2.1 Modified Boxplots for Gamma Dose ...................................................................... 18 

4.2.2 Modified Boxplots for Beta Dose............................................................................ 24 

4.3 Analysis by Departments..................................................................................................... 30 

4.3.1 Departmental Gamma Doses ................................................................................... 30 

4.3.2 Departmental Beta Doses ........................................................................................ 34 

4.4 Comparing 1961 Gamma Dose Distributions of Workers Monitored Versus Not Monitored 

in 1960 .......................................................................................................................................... 36 

4.4.1 Analysis of “Why Not Monitored?” Group for Gamma Doses .............................. 39 

4.5 Comparison of Maximum Monitoring Data Results ........................................................... 43
 

5.0 Additional Analysis by Department ............................................................................................. 44 

5.1 Gamma Dose Analysis ........................................................................................................ 44 

5.2 Beta Dose Analysis.............................................................................................................. 62
 

6.0 References .................................................................................................................................... 81 

3 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028
 

Tables 

Table 3-1: Headings and Data as Presented in Health Physics Report1 ................................................ 12 

Table 3-2: July- December 1952 Comparison of Percentiles Reported in Y-12 HP Reports Versus
 

Percentiles Calculated from Y-12 Database1 ........................................................................................ 13 

Table 3-3: Comparison of Delta View Results to Y-12 Database Results ............................................ 15
 

Table 4-1: Job Activities and Duties for 147 Long-Term Y-12 Workers ............................................. 17 

Table 4-7: Descriptive Statistics for 1961 Y-12 Quarterly Gamma Doses for Two Groups of Workers 

Table 4-8A: Job and 1961 Gamma Dose Information for Y-12 Workers Not Selected for Monitoring 

Table 4-8B: Job and 1961 Gamma Dose Information for Y-12 Workers Not Selected for Monitoring 

Table 4-8C: Job and 1961 Gamma Dose Information for Y-12 Workers Not Selected for Monitoring 

Table 4-8D: Job and 1961 Gamma Dose Information for Y-12 Workers Not Selected for Monitoring 

Selected for Regression Analysis of Gamma Doses ............................................................................. 17 

Table 4-2: Job Activities and Duties for 182 Long-Term Y-12 Workers ............................................. 17 

Selected for Regression Analysis of Beta Doses................................................................................... 17 

Table 4-3: Product Limit Estimate Summary Stats for Y-12 Quarterly Gamma Doses, 1952-1979 ... 19 

Table 4-4: Product Limit Estimate Summary Stats for Y-12 Quarterly Beta Doses, 1952-1979 ......... 25 

Table 4-5A: Y-12 Gamma Doses Ordered by Adjusted Mean Dose, 1961-1965 ................................. 31 

Table 4-5B: Y-12 Gamma Doses Ordered by Adjusted Mean Dose, 1961-1965 ................................. 32 

Table 4-5C: Y-12 Gamma Doses Ordered by Adjusted Mean Dose, 1961-1965 ................................. 33 

Table 4-6B: Y-12 Beta Doses 1956-1965 Order by Adjusted Mean Dose, 1956-1960 ........................ 35 

Table 4-6C: Y-12 Beta Doses 1956-1965 Order by Adjusted mean dose, 1956-1960 ......................... 36 

Partitioned by Monitoring Status in 1960 ............................................................................................. 38 

in 1960 and Having a Quarterly Dose above 300 mrem in 1961 .......................................................... 40 

in 1960 and Having a Quarterly Dose above 300 mrem in 1961 .......................................................... 41 

in 1960 and Having a Quarterly Dose above 300 mrem in 1961 .......................................................... 42 

in 1960 and Having a Quarterly Dose above 300 mrem in 1961 .......................................................... 42 

Table 4-9: Comparison of Maximum Internal and External Annual Monitoring Resultsa

 Between .... 44 

Members of the Proposed Classb

 and Non-Class Membersc ................................................................. 44
 

Table 5-1: Department 2233 Summary Statistics for Gamma Doses.................................................... 46 

Table 5-2: Department 2618 Summary Statistics for Gamma Doses.................................................... 46 

Table 5-3: Department 2619 Summary Statistics for Gamma Doses.................................................... 50 

Table 5-4: Department 2701 Summary Statistics for Gamma Doses.................................................... 52 

Table 5-5: Department 2702 Summary Statistics for Gamma Doses.................................................... 54 

Table 5-6: Department 2703 Summary Statistics for Gamma Doses.................................................... 56 

Table 5-7: Department 2793 Summary Statistics for Gamma Doses.................................................... 58 

Table 5-8: Department 2014 Summary Statistics for Gamma Doses.................................................... 60 

Table 5-9: Department 2018 Summary Statistics for Gamma Doses.................................................... 60 

Table 5-10: Department 2233 Summary Statistics................................................................................ 64 

Table 5-11: Department 2618 Summary Statistics................................................................................ 64 

Table 5-12: Department 2619 Summary Statistics................................................................................ 68 

Table 5-13: Department 2701 Summary Statistics................................................................................ 70 

Table 5-14: Department 2702 Summary Statistics................................................................................ 72 

Table 5-15: Department 2703 Summary Statistics................................................................................ 74 

Table 5-16: Department 2793 Summary Statistics................................................................................ 76 

Table 5-17: Department 2014 Summary Statistics................................................................................ 78 

Table 5-18: Department 2018 Summary Statistics................................................................................ 79 

4 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028
 

Figures 

Figure 1a: Modified Boxplot for Gamma Doses, 1952-1979................................................................ 23 

Figure 3. Histograms for Y-12 Quarterly Gamma Doses in 1961 for Two Groups of Workers 

Figure 4. Modified Box Plots for Y-12 Quarterly Gamma Doses in 1961 for Two Groups of Workers 

Figure 1b. Additional Summary Information for Gamma Doses, 1952-1979 ...................................... 24 

Figure 2a. Modified Boxplot for Beta Doses, 1952-1979 ..................................................................... 29 

Figure 2b. Additional Summary Information for Beta Doses, 1952-1979 ............................................ 30 

Partitioned by Monitoring Status in 1960 ............................................................................................. 37 

Partitioned by Monitoring Status in 1960 ............................................................................................. 38 

Figure 5. Modified Boxplot for Gamma Doses in Department 2233 .................................................... 45 

Figure 6. Modified Boxplot for Gamma Doses in Department 2618 .................................................... 48 

Figure 7. Modified Boxplot for Gamma Doses in Department 2619 .................................................... 49 

Figure 8. Modified Boxplot for Gamma Doses in Department 2701 .................................................... 51 

Figure 9. Modified Boxplot for Gamma Doses in Department 2702 .................................................... 53 

Figure 10. Modified Boxplot for Gamma Doses in Department 2703 .................................................. 55 

Figure 11. Modified Boxplot for Gamma Doses in Department 2793 .................................................. 57 

Figure 12. Modified Boxplot for Gamma Doses in Department 2014 .................................................. 59 

Figure 13. Modified Boxplot for Gamma Doses in Department 2018 .................................................. 62 

Figure 14. Modified Boxplot for Beta Doses in Department 2233, 1956-1965 .................................... 63 

Figure 15. Modified Boxplot for Beta Doses in Department 2618, 1956-1965 .................................... 66 

Figure 16. Modified Boxplot for Beta Doses in Department 2619, 1956-1965 .................................... 67 

Figure 17. Modified Boxplot for Beta Doses in Department 2701, 1956-1965 .................................... 69 

Figure 18. Modified Boxplot for Beta Doses in Department 2702, 1956-1965 .................................... 71 

Figure 19. Modified Boxplot for Beta Doses in Department 2703, 1956-1965 .................................... 73 

Figure 20. Modified Boxplot for Beta Doses in Department 2793, 1956-1965 .................................... 75 

Figure 21. Modified Boxplot for Beta Doses in Department 2014, 1956-1965 .................................... 77 

Figure 22. Modified Boxplot for Beta Doses in Department 2018, 1956-1965 .................................... 80 

5 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

This page intentionally blank 

6 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Monitoring Data Sufficiency –Appendix 1 for SEC-00028 

1.0 Y-12 Health Physics Progress Reports 

The Health Physics Progress Reports’ general content and purpose are summarized in Section 4.0. 

The Y-12 Health Physics Progress Reports reflect an established Health Physics Program that was 

state-of-the-art and continually developing. Examination of the monitoring performed indicates a 

departmental effort to measure process and personal exposures associated with activities having the 

highest exposure potential at Y-12. Based on the Y-12 program information identified during 

document reviews, compliance with applicable standards was emphasized. Additional types of 

supporting information and documentation include personnel sampling protocols, Health and 

Safety/Health Physics procedures, personnel training, and recommendations made to increase worker 

safety (e.g., increased ventilation, personal protective equipment use, or new shielding requirements). 

As indicated from the Y-12 Health Physics Progress Reports, all areas and activities were monitored 

on some frequency; production areas and specific jobs well known for exposure potential (see Section 

5.0 of the Y-12 Evaluation Report, SEC-00028 ) were monitored constantly. The monitoring results 

for employees associated with known high exposure potential jobs were routinely documented in the 

reports. Contamination and exposure potentials associated with new and/or short duration research 

and developmental type activities were also assessed and documented. Long-term, non-uranium 

production activities such as the cyclotron work were given regular attention within the monitoring 

program and progress reports (see Section 5.0 of the Y-12 Evaluation Report, SEC-00028). The Y-12 

Health Physics Progress Reports also clearly show that training and orientation sessions were 

provided by the Health Physics Department for all associate employees. 

Information contained within the Y-12 Health Physics Progress Reports shows that monitoring was 

performed for Y-12 activities involving the highest exposure potentials for production operations and 

non-production research and development activities. This supports the assumption that it is 

appropriate to use the resultant monitoring data in the evaluation/calculation of maximum exposure 

potentials for the proposed class of Y-12 workers in this evaluation. It is notable, however, that the 

reports record recurrent elevated contamination levels associated with certain operations despite 

recommendations for engineering and/or operational control changes. This situation reflects 

organizational responsibilities in effect at the time; production supervisors and department heads 

ultimately possessed the authority for making decisions regarding implementation of the health 

physicists’ recommended changes. While failures to expedite production refinements to minimize 

exposure potentials may have lead to increased doses to certain workers, the sufficiency of the 

monitoring data for calculating maximum possible doses received is not affected. 

2.0 Y-12 Employee Interviews 

NIOSH conducted interviews with former Y-12 Plant employees. The interview process included a 

short introduction to the EEOICPA process and the SEC-00028 Evaluation Report effort. Each person 

interviewed was asked to focus on Y-12 and the 1948 through1958 time period. Interview discussion 

was focused on the personnel monitoring selection process as well as determining how focused the 

program was on overall worker safety. Interviews conducted with the analytical laboratory employees 

focused on the quality control measures used at Y-12 and the handling of analytical data. Other 

7 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

interviews were held specifically to gain knowledge of weapons assembly/disassembly operations 

during the proposed class time period. 

In general, the employee interview responses were similar among those interviewed and to the 

information contained within the Y-12 Health Physics Progress Reports. The employee interview 

results also support the concept that it is appropriate to use the available monitoring data in the 

evaluation/calculation of maximum exposure scenario doses for proposed class of Y-12 workers in 

this evaluation. The health physicists interviewed were adamant that: 

•	 Highest exposure activities were determined and carefully monitored (areas and employees) 

•	 Expected clean areas (e.g. hallways, break areas) were routinely surveyed for contamination 

•	 New, developmental, and/or research oriented work was always approached very cautiously and 

monitored thoroughly 

Other interview results include: 

•	 Of the employees interviewed that could remember, each stated that respirator use was required 

and implemented for specific 

•	 One supervisor recalled that failure to use respirators when required was subject to reprimand 

•	 With the exception of a single employee interviewed, all said that eating, drinking, and smoking 

was allowed only in designated areas 

•	 Most of the workers interviewed recalled that containing contamination was a constant problem— 

Workers were constantly cleaning in an attempt to limit the spread of contamination 

•	 Essentially, all interviewed remembered a management level (Carbide) emphasis on workplace 

safety— Regular safety meetings were held where workplace hazards were discussed and lost time 

accidents were reviewed 

Many of the people interviewed confirmed the organizational responsibilities outlined in the Health 

Physics Progress reports as well as other reports. These generally included: 

•	 Supervisor’s were responsible for implementing safety requirements 

•	 Health Physicists reported contamination and potential exposure readings and subsequently 

provided direction to supervisors regarding needed process changes, shielding, and respirator use e 

3.0 Credibility, Validity, and Representativeness of Data 

For this petition evaluation, NIOSH reviewed all of the available exposure data for Y-12 and then 

focused on key sets of exposure data to determine if those data are adequate for completing individual 

dose reconstructions for all members of the class. As such, the “credibility”, “validity”, and 

“representativeness” of the data sets must be determined. Based on a premise that members of the 

proposed class could have been associated with many, if not most plant activities, key data sets are 

defined as those required to assess sources of exposure and internal and external monitoring data for 

workers involved. The following discussions pertain to the available monitoring data with a focus on 

internal and external monitoring records from during, and soon after the proposed class time frame. 

Credibility and validity of the data has been has been assessed by examining the following data 

characteristics: 

•	 “Pedigree” of the data 

•	 Original Y-12 methodology used to obtain the data 

8 of 81-Appendix 1 
 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

• Internal consistency of the data 

These three aspects of the data set evaluations are discussed individually in the subsections that 

follow. 

Assessments and discussions pertaining to the representativeness of key data have already been 

performed and presented in this report in Sections 5.0, 6.0 and 7.0. To complete the assessment, data 

sets were reviewed in terms of: 

• The areas of the facility represented 

• Application to the proposed class time period 

• Types of workers and processes covered 

• Quantity and representativeness of the highest exposed workers 

Results of the assessments are that the available key data are sufficiently representative of the 

proposed class being evaluated and therefore appropriate for use in the calculation of radiation doses 

for members of the class. 

3.1 Pedigree of the Data 

NIOSH reviewed all of the available Y-12 exposure data to determine if the data are adequate for 

completing individual dose reconstructions for all members of the proposed class. Examination of the 

monitoring data “pedigree” involves determining the intent of the original exposure evaluations, the 

relation of the exposure monitoring to documented activities at the site during the proposed class time 

period, and the history of the data set(s) being used. As part of the data set history investigation, 

NIOSH must ensure that if secondary (not original) sources of data are used, these data are consistent 

with the original data set. 

The intent of the Y-12 Health Physics Program was well documented. It is clear that the focus of the 

program was to determine and monitor all potential exposure areas and activities within the plant, 

minimize exposure potentials, and document compliance with applicable standards. This is evidenced 

by information available in a multitude of memos that have been obtained and reviewed (see Section 

4.0), Health Physics Progress Reports (see sections 4.8, 6.5, and 1.0 above), and from worker 

interviews (2.0, above). NIOSH has obtained no information from any of the aforementioned sources 

that would indicate the Y-12 Health Physics program failed to adequately monitor known, or 

new/potential sources of exposure. Furthermore, NIOSH has no indication that results of these 

monitoring efforts were not properly documented and/or recorded in the monitoring records. 

The history of the Center for Epidemiological Research (CER) data is also well known. The 

monitoring data contained within this CER database are a direct copy of the Y-12 Health Physics 

routine Monitoring Program record and is absolutely consistent with the original data. Information 

and data associated with non-uranium sampling and other non-routine activities at Y-12 are stored 

within the Delta View Imaging System (Section 4.8). Discussions with Y-12 personnel indicate that 

the Delta View system is used to ensure the capture of analytical results separate from those 

associated with the more routine processing activities. The Delta View Database resides with and is 

maintained by Y-12. Like the CER Database, the Delta View Database also represents original data. 

Copies of these data are available to NIOSH as needed and/or requested. 

9 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

3.2 Methodology 

Recognizing that radiation monitoring and analytical methods have varied significantly from site to 

site and over time, NIOSH evaluated the documented methodologies underlying the data (as available) 

to determine the data’s suitability for dose reconstruction. This evaluation included assessing whether 

reliable corrective estimation procedures have been applied to the data and if so, whether or not they 

were appropriate. 

Extensive documentation produced and preserved by the Y-12 Health Physics Department has 

allowed NIOSH to successfully accomplish the monitoring methodology assessment. Much of the 

information directly affecting data quality has been obtained, compiled, and summarized in the 

following documents: 

•	 TBD for the Y-12 Plant – Occupational Environmental Dose, ORAUT-0014-4; October 11, 2005 

•	 TBD for the Y-12 Plant – Occupational Internal Dose, ORAUT-0014-5; February 14, 2006 

•	 Technical Information Bulletin: External Radiation Monitoring at Y-12 During 1948-1949 Period, 

Rev. 01, ORAUT-OTIB-0047; September 20, 2005 

•	 Historical Evaluation of the Film Badge Dosimetry Program at the Y-12 Facility in Oak Ridge, 

Tennessee: Part 1—Gamma Radiation 

The types of information available from the proposed class time frame include radiation and analytespecific sampling techniques, sampling devices used, sampling frequency, minimum detection limits, 

uncertainty and interferences, and calculations/conversions performed. Changes that occurred within 

these parameters over time have also been captured and presented in the abovementioned Y-12 

documents. 

In addition, available documentation describes a monitoring program that was continually improving. 

Despite its evolutionary nature, the sampling and measurement methodologies used at Y-12 from 

1948 through 1957 represented the state of the art for the time. Y-12 correspondence describes 

frequent collaboration with ORNL and many other AEC facilities and Universities (e.g. University of 

Rochester) in their continued efforts to develop and improve external and bioassay monitoring 

methodology and procedures. Additionally, references to the use of National Council of Radiation 

Protection (NCRP) standards, AEC orders for exposure limits and other regulatory/administrative 

limits and control measures are prevalent in Y-12 documents, as are documentation regarding “special 

studies” which were conducted to test and improve methods being used. 

NIOSH has concluded that sampling and analytical methodologies used during the proposed class 

timeframe produced data sufficient for use in dose reconstructions. Required adjustments resulting 

from method uncertainties are necessary to ensure that claimant-favorability have been documented in 

the abovementioned documents and in: 

•	 Technical Information Bulletin: Individual Dose Adjustment Procedure forY-12 Dose 

Reconstruction, ORAUT-OTIB-0013 

•	 Technical Information Bulletin: Internal Dosimetry Coworker Data for Y-12, ORAUT-OTIB0029 

3.3 Data Consistency 

10 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Evaluating data consistency involves comparing monitoring data references and primary data 

repositories. NIOSH has compared monitoring data references and primary data repositories as a spot 

check for data handling errors. Data handling errors include errors associated with transcription, data 

entry, and record maintenance. Data consistency was examined by comparing: 

•	 Individual external monitoring results presented on documents captured within the Delta View 

imaging system were compared to results maintained in the Y-12 electronic record 

•	 The number of urinalysis samples reported in Y-12 Health Physics Progress Reports were 

compared to the numbers of data records present in the Y-12 electronic record 

•	 Monitoring result values reported in Y-12 Health Physics Progress Reports were compared to the 

Y-12 electronic record 

•	 Uranium urinalysis results that were hand written on individual analytical record “punch cards” 

were compared to the Y-12 electronic record 

3.3.1 Reported Analysis Totals and General Data References 

A comparison of the number of uranium urinalyses performed as cited in the Health Physics Progress 

Reports to the number of urinalysis results contained in the CER Database indicates that there were 

typically more urinalyses reported than results entered into the Y-12 Electronic Record. However, 

interviews with two laboratory workers revealed that to their knowledge, it was always standard 

analytical procedure to include many additional quality control analyses such as blanks, standards, and 

matrix spikes. It was likely that these types of analyses were included in the totals cited in the reports, 

but not in the individual monitoring record. Additionally, interviews revealed that analysts would 

frequently perform more than one analysis (same and/or different analytical technique) from an 

individual sample as a quality control check. Unexpected discrepancies would warrant even more 

analyses and/or re-sampling. For example, one uranium urinalysis technician stated that during his 

two year tenure at Y-12, his routine procedure included performing fluorometric and gross alpha 

methods on nearly all samples as a quality control check to make sure potential exposures were not 

being missed. 

Comparisons of external monitoring data also showed discrepancies between the number of film 

badges processed as recorded in the Y-12 Health Physics Progress Reports and the number of film 

badge results present in the Y-12 Database. These differences are due to the frequency of the 

exchange and processing activities.Y-12 summarized the film badge readings stored in the database 

into quarterly readings while the actual film badge exchange and processing rate was much more 

frequent: weekly in the early 1950s. 

3.3.2 Reported Urinalysis Results 

For the most part, Y-12 Health Physics Progress Reports report monitoring results in general terms 

that describe groups of workers. The Y-12 Health Physics Progress Report data are generally 

presented as ranges of exposures for workers and stress compliance with applicable standards. 

Therefore, the Y-12 Health Physics Progress Reports provide only limited opportunities for direct 

comparisons to individual monitoring results contained in the Y-12 Database. However, several data 

comparisons possibilities were identified. Results of these comparisons are described below. 

11 of 81-Appendix 1 
 

Number of Analyses 

Exceeding MPL2

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Averaged uranium urinalysis results for the month of October 1953 were located for 22 Y-12 workers 

in a classified November 13, 1953 Y-12 Health Physics Progress Report. These results were compared 

to the Y-12 Database and the results are presented in Table 3-1. 

With one exception, averages of results in the Y-12 record were identical to the average weekly 

excretion rates reported in the Y-12 Health Physics Progress Report. For one worker, worker # 13, 

three results were found in the Y-12 Database with values of 157, 152, and 2. The results of 152 and 2 

were recorded for the same day. The average dpm/24hr for all three values is 104; excluding the 2 

dpm/24 result yielded an average of 155, as reported in the November 13, 1953 Y-12 Health Physics 

Progress Report. It is assumed that the authors of the 1953 report decided it was appropriate to not use 

the questionably low result in their summary. Serving as the official record, it would be expected that 

the questionable result remain part of the Y-12 Database. 

Table 3-1: Headings and Data as Presented in Health Physics Report1 

Y-12 Database Results for 

October 1953 

(Averaged)3 

Individual Number of Analyses 

During October 

Average of Weekly 

Excretion Rates 

d/m/24hrs 

1 2 2 212 212 

2 2 2 167 167 

3 2 2 736 736 

4 2 2 127 127 

5 2 2 110 110 

6 2 2 101 101 

7 3 2 89 89 

8 2 2 143 143 

9 3 2 88 88 

10 3 2 88 88 

11 2 2 181 181 

12 2 2 210 210 

13 2 2 155 104 

14 3 3 241 241 

15 2 2 110 110 

16 1 1 458 458 

17 2 2 78 78 

18 2 2 126 126 

19 3 2 344 344 

20 2 1 2,100 2,100 

21 3 1 199 199 

22 2 1 352 352 

Notes: 

1

 It should be noted that data points were not individually labeled on the Health Physics Progress Report graphs. 

Therefore, minor transcription errors are inherent with the data interpretation process. 2 Maximum Permissible Limit
 3 Results in dpm/24hour voiding
 

In addition to the individual monitoring results comparison, another comparison was made that 

graphed weekly 50th, 75th, and 90th percentile monitoring results reported in a July through December 

1952 Y-12 Health Physics Progress Report. The 1952 Health Physics Progress Report was compared 

against weekly percentiles calculated from the Y-12 Database for the same July through December 

1952 time period. The following table, Table 3-2, presents the results of the comparison. 

12 of 81-Appendix 1 
 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 3-2: July- December 1952 Comparison of Percentiles Reported in Y-12 HP Reports Versus Percentiles 

Calculated from Y-12 Database1 

Percentiles 

50th 75th 90th 

Week 

HP Report 

July-December 

1952 

Y-12 

Database 

HP Report 

July-December 

1952 

Y-12 

Database 

HP Report 

July-December 

1952 

Y-12 

Database 

31 17 16 30 30 30 45 

32 16 16 31 31 46 48.5 

33 9.4 8 18 16 47 31 

34 9 8 21 17 29 29 

35 13 13 26 24 39 37 

36 14 16 29 30 51 51 

37 18 16 34 36 60 72 

38 14 15 31 25 41 43 

39 13 12 30 26.5 43 46 

40 16 14 40 30.5 55 57 

41 13 14.5 31 24.5 48 46 

42 39 35 62 61 93 98 

43 20 20 33 32.5 63 64 

44 19 19 35 38 70 75.5 

45 21 20 39 37 63 65 

46 17 16 32 32 70 61 

47 19 21 34 36 64 64 

48 16 16.5 28 28 60 66 

49 12 12 25 25 50 51 

50 15 16 23 39 53 57 

51 13 16 26 29 41 52 

52 20 20 24 43.5 91 97 

Note: 

1

 Comparison of DPM/24 hours 

DPM= disintegrations per minute 

Results listed in Table 3-2 show that the monitoring results calculated from the Y-12 Database are 

consistent with those displayed graphically within the Y-12 Health Physics Progress Reports. 

Two additional comparisons were performed using the Y-12 Health Physics Progress Reports. First, 

the January 1, 1952 through July 1, 1952 Health Physics Progress Report made reference to a 

percentage of urinalysis samples exceeding the maximum permissible limit (MPL) of 70 dpm/24 hour 

voiding (disintegrations per minute per 24 hour voiding period) and to a maximum urinalysis result 

(February 19, 1953). Page 30 of the January 1, 1952 through July 1, 1952 Health Physics Progress 

Report contains the following statement: 

“To date, 10 to 30 per cent of the total number of urine samples analyzed for enriched uranium 

have exceeded the MPL of 70 d/m/24-hour voiding. Efforts to decrease this number.....” 

It is assumed that the range of above-MPL results reflects the range of weekly or monthly assessments 

made within the six-month summary report period. Examination of the electronic record yielded a 

result of 18 % of the results for the six-month period being above the MPL. 

Second, the November 1, 1950 through December 31, 1950 Y-12 Health Physics Progress Report 

stated that the highest excretion level of (enriched) uranium was 795 dpm/24hr. Querying the 

13 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

electronic database for the highest uranium result for the same time period yielded the same result, 

795 dpm/24hr. 

3.3.3 Punch Cards Data Comparison 

Data consistency was further examined by comparing data recorded on IBM punch cards to the Y-12 

Database. The punch cards were used to record Y-12 employee monitoring information for decades. 

Interviews with Y-12 employees indicate that punch cards might have been used as early as 1948, but 

were certainly used as far back as the early 1950’s. The cards were prepared with worker 

identification data and accompanied an individual’s bioassay sample to the analytical laboratory. 

Sample information details were commonly recorded by hand directly onto the punch cards during the 

time of analysis. Typical identification-type information included on the punch cards included worker 

ID, sample date, sample volume, time interval, and work department. Also included and written 

directly on many of the punch cares was raw analytical count data. 

Although to date, NIOSH has been unable to locate punch cards corresponding to the 1948 through 

1957 time period, punch cards containing hand written sample details and analytical counts were 

located for analyses run in the mid-1970s. These later period punch cards were then used to check the 

consistency of the Y-12 Database in terms of the flow of data from the laboratory to its final entry into 

the Y-12 Database. 

Thirty six punch cards containing worker identification, sample details, and raw analytical count data 

were selected for comparison to the Y-12 Database. The names, identification numbers, and sample 

information such as void times, sample size, and sample dates listed on the punch cards corresponded 

precisely with information stored in the Y-12 Database for all 36 cards. Comparing the raw analytical 

count data present on the punch cards to corresponding final results recorded in the Y-12 Database 

requires the application of a well documented mathematical algorithm. The mathematical algorithm 

requires sample specific parameters and analytical conditions. However, variables specific to 

analytical runs such as background measurements and plating recovery were not present on the punch 

cards, thus preventing a direct comparison of the data. Nevertheless, using plating recoveries and 

background numbers described as “typical” or “desired” from available Y-12 literature (McLendon, 

1963) in the algorithm and then applying the numbers to the punch card data yielded results very close 

to the Y-12 Database. 

3.3.4 External Monitoring Results 

The consistency of external monitoring data was checked by comparing individual weekly monitoring 

results to quarterly and yearly results contained within the Y-12 Electronic Record. The weekly results 

were obtained from summary sheets maintained in the Delta View imaging system. Over 1,000 Delta 

View images were reviewed and resulted in a compilation of a nearly complete set of 1953 weekly 

results for 28 Y-12 employees. Of these 28 individuals identified, 12 had at least one positive weekly 

result. Querying theY-12 Electronic Database for records associated with the 28 identified workers 

yielded positive results for the same subset of 12 workers. 

The following table, Table 3-3, compares the sums of the 1953 weekly Delta View results to sums of 

the quarterly results recorded in the Y-12 Electronic Database. Given the errors associated with this 

comparison, as described below the table, the data compare favorably and indicate strong consistency. 

Delta View beta results are identical to those recorded in the Y-12 Electronic Database for all but two 

14 of 81-Appendix 1 
 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

individuals for which the Electronic Database record is higher. These two discrepancies in the beta 

results could be caused by one or more of the errors described below Table 3-3. 

Gamma results also compare favorably provided that the indicated 50mrem detection limit is added 

into the Delta View total. Similar to the beta results, it appears that the discrepancies are likely caused 

by the known errors listed below. 

Table 3-3: Comparison of Delta View Results to Y-12 Database Results 

Individual DV 

Beta1 

DB 

Beta2 

DV 

Gamma3 DV + 50/*4 DB Gamma5 

1 0 0 226 336 238 

2 325 725 570 2,620 2,694 

3 66 66 745 2,695 2,866 

4 0 0 120 2,300 2,640 

5 0 0 0 2,250 2,486 

6 58 58 811 2,711 2,854 

7 0 0 120 2,420 2,562 

8 50 50 220 1,770 1,998 

9 0 0 52 952 921 

10 0 0 0 1,800 1,986 

11 349 379 2,388 3,488 3,026 

12 0 0 0 2,300 2,586 

Notes: 

1

 Delta View beta results – totals of the real numbers only 2

 Database beta results – totals of the four 1953 quarters 

3

 Delta View gamma results – totals of the real numbers only 4

 Delta View real number gamma results plus 50 mrem for each * present (as denoted on the Delta View data 

sheets)

5

 Database gamma results – totals of the four 1953 quarters 

Known errors/uncertainties inherent with this evaluation are as follows: 

1.	 Each weekly summary consisted of names typed onto a table spanning two pages. Examining the 

images in the sequence provided by the Delta View system indicated a logical sequencing of a 

given week’s first page with its respective second page. However, only the first page contains the 

date, therefore it is impossible to be certain that the second page of names is actually from the 

correct week. 

2.	 Some of the results were very difficult and/or impossible to read. Best judgment was used in the 

data entry process. 

3.	 Weeks “1” and “32” were missing, weeks “53” and “54” (an overlap into the next year) were 

partial - the second page of results could not be found. 

4.0 Statistical Analysis of Monitoring Data 

Analyses of external monitoring data were performed to further investigate the assertion that 

individuals selected for external monitoring prior to 1961 were workers with the highest exposure 

potential. In general, comparisons were made between pre-1961 monitoring data sets and 1961-1979 

data sets. Personal external monitoring coverage prior to 1961 peaked out at approximately 20 % of 

the workforce. However, monitoring program changes implemented in 1961 resulted in essentially the 

entire workforce being monitored. This program change allows for exposure level comparisons 

15 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

between the two time periods on a departmental and individual basis. Increases or decreases in 

exposure levels between the two time periods can then be used to support or refute the assertion that 

the highest exposure activities and personnel prior to 1961 were targeted for monitoring. 

The following analyses were performed: 

1.	 An examination of job titles and duties for two groups of workers selected regularly for 

monitoring before 1961 and used for regression analysis 

2.	 Analysis of modified boxplots presenting distributions of beta and gamma doses prior to and after 

1961 

3.	 Analysis of beta and gamma doses by departments 

4.	 An investigation of gamma doses in 1960 for workers with a quarterly doses greater than 10% of 

Radiation Protection Guidelines in 1961 

5.	 Maximum internal and external monitoring results were compared between class members 

(plumbers, pipefitters and steamfitters) and non-class members with the job titles based on the 

gamma dose regression group and the beta dose regression group 

4.1 Job Type Analysis of Y-12 Workers Selected for Regression Analysis 

Members of the gamma dose and beta dose regression data groups were long-term employees of Y-12 

who had been monitored regularly. Therefore, an analysis of their jobs provides insight into the types 

of workers who were selected for monitoring before blanket monitoring became policy in 1961. 

Because both groups had selection criteria that included regular monitoring before 1961 when fewer 

than 20% of the workers were generally monitored during any given year, there was necessarily an 

overlap of individuals between the two groups. Of the 147 gamma group members and the 182 beta 

group members, there were 113 individuals common to both groups. 

Using a work history database acquired by ORAU from Y-12, all job titles with corresponding dates 

were obtained for each of the two groups of workers (ORAU Technical Report 2004-0888). 

Frequently, multiple job titles for an individual showed a progression of promotions as skills and 

seniority were gained. A recurring example was the progression from machine operator to specialty 

machinist to machinist and, occasionally, to supervisor of machining. For each individual in each 

group, the job held during the majority of the 1956 through 1960 time period was selected. This job 

was classified by type of activity (e.g., machining) and duties (worker, foreman, supervisor, or 

manager). 

4.1.1 Gamma-Dose Regression Groups 

The gamma dose regression group consisted of 147 Y-12 workers who had been monitored regularly 

both before and after 1961. The group was selected to investigate whether gamma dose potential in 

the earlier years was higher than in later years of the film badge period. Each of these 147 workers 

satisfied the criteria of possessing four quarters of gamma dose records per year for at least five years 

during each of the two time periods 1952 through 1960 and 1961 through 1970. The 5,686 quarterly 

doses for these workers between 1956 and 1965 were used for a regression analysis, the results of 

which were available for inferring gamma doses for unmonitored quarters before 1956 (ORAU 

Technical Report 2004-0888). 

16 of 81-Appendix 1 
 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-1 presents the results of the job analysis for the gamma dose regression group. Among the 

147 employees, 129 (88%) were involved in performing tasks that involved no management or 

supervisory components. Most of these 129 were machinists, chemical or production operators, or fire 

and security workers. Another 14 (10%) members of this group carried out some supervisory tasks, 

such as fire captains, laboratory, inspection, or production supervisors, or foreman. The foreman likely 

had similar exposure potential as their workers, and the supervisors may have had somewhat similar 

exposure as the workers they were supervising. Only four (3%) of the 147 individuals were managers, 

including one superintendent of utilities, one shift superintendent, and two assistant shift 

superintendents. 

Table 4-1: Job Activities and Duties for 147 Long-Term Y-12 Workers 

Selected for Regression Analysis of Gamma Doses 

Activity Duties Number of Workers 

Fire and Security Supervisor 5 

Fire and Security Worker 14 

Inspection Supervisor 1 

Inspection Worker 6 

Laboratory Work Supervisor 3 

Laboratory Work Worker 6 

Machining Worker 71 

Management Manager 4 

Medical Worker 1 

Production Foreman 4 

Production Supervisor 1 

Production Worker 28 

Production Support Worker 2 

Research and Development Worker 1 

4.1.2 Beta-Dose Regression Groups 

The beta dose regression group is a set of 182 Y-12 workers who had been monitored both before and 

after 1961 and worked in departments with beta-particle exposure potential. Members of this subgroup 

provided 4805 quarterly doses and had at least four quarterly film badges after 1960 and at least 24 

before 1961. These quarterly doses provided the basis for a regression analysis the results of which 

can be used to estimate quarterly beta dose distributions for unmonitored quarters before 1956. 

The table below, Table 4-2, presents the results of the job analysis for the beta dose regression group. 

Among the 182 employees, 156 (86%) were involved in performing tasks that involved no 

management or supervisory components. Most of these were machinists, chemical or production 

operators, or fire and security workers. Another 23 (13%) members of this group carried out some 

supervisory tasks, such as fire captains, laboratory, inspection, or production supervisors, or foreman. 

The foreman likely had similar exposure potential as their workers, and the supervisors may have had 

somewhat similar exposure as the workers they were supervising. Only 3 (2%) of the 182 individuals 

were managers, including one shift superintendent and two assistant shift superintendents. 

Table 4-2: Job Activities and Duties for 182 Long-Term Y-12 Workers 

Selected for Regression Analysis of Beta Doses 

Activity Duties Number of Workers 

Crafts Foreman 5 

Fire and Security Supervisor 5 

Fire and Security Worker 16 

17 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-2: Job Activities and Duties for 182 Long-Term Y-12 Workers 

Selected for Regression Analysis of Beta Doses 

Activity Duties Number of Workers 

Inspection Supervisor 1 

Inspection Worker 9 

Laboratory Work Supervisor 4 

Laboratory Work Worker 5 

Machining Worker 65 

Management Manager 3 

Medical Worker 1 

Production Foreman 7 

Production Supervisor 1 

Production Worker 43 

Production Support Worker 17 

4.2 Analysis Using Modified Boxplots 

A modified version of a box plot was used to summarize the gamma and beta film badge doses. For 

each quarter the Kaplan-Meier (K-M) product limit estimate (PLE) of the empirical distribution 

function was calculated as described in Frome and Watkins. 

A large number of the doses were recorded as zero. Each dose recorded as zero was treated as a left 

censored value at a detection limit of 30 mrem. The PLE adjusts for non-detects, which occurred in 

most of the quarters. A conventional boxplot is obtained by calculating the 25th quantile, xq25, and 

the 75th quantile, xq75, which define the ends of the box that contain the central 50 percent of the 

data. A modified boxplot is obtained by calculating the 25th and 75th quantiles using inverse 

interpolation from the PLE to take non-detects into account. 

Large "outliers" for each quarter are identified by calculating the value of xq75 + 1.5*(xq75 - xq25), 

and all data points that exceed this value are shown in the box plot by a separate symbol, such as a 

“+”, for each outlier. Small "outliers" are identified by calculating the quarterly value of xq25 - 

1.5*(xq75 - xq25), and all positive data less than this value are shown separately in the boxplot. The 

modified boxplots in this report show xq25 as a blue inverted triangle and xq75 as a green triangle, 

and the box connecting these quantiles is not drawn. The maximum dose is shown as a red circle, and 

the minimum dose is a red diamond when no left censored data were present. Each dose in a quarter 

that exceeded (on log scale) log(xq75) + 1.5*[ log(xq75) - log(xq25) ] is shown as a black plus sign 

(+) . All data points in a quarter that are less than (on log scale) log(xq25) - 1.5*[ log(xq75) - 

log(xq25) ] are also shown as plus signs, although these may be incomplete when there were a large 

number of zero doses. The percent zeros, percent positive outliers, number of film badge readings, and 

censoring adjusted K-M means are shown as part of the modified boxplot. 

The adjusted cumulative dose is an estimate of the total dose adjusted for non-detects (zero doses), 

and is obtained by multiplying the K-M mean by the number of doses, i.e., cdosea=n*kmm. An 

estimate of missed dose (for monitored workers) is obtained by subtracting the cumulative dose from 

the adjusted cumulative dose. 

4.2.1 Modified Boxplots for Gamma Dose 

18 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Each of the 426,621 beta doses recorded for Y-12 workers from 1952 to 1979 had a corresponding 

gamma dose for the same individual in that quarter. Because workers were selected for external dose 

monitoring before 1961 based mainly on potential exposure to beta particles, the gamma dose records 

contained a larger number of non-detects recorded as zeros or assigned the MDL (ORAU Technical 

Report 2004-0888). 

Table 4-3 provides the summary statistics for all recorded gamma doses from 1952-1979. These 

statistics were used to produce the modified boxplot for Figure 1a. Plots with additional summary 

information by quarter are provided in Figure 1b. 

Table 4-3: Product Limit Estimate Summary Stats for Y-12 Quarterly Gamma Doses, 1952-1979 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

52 Q1 111.7 9.8 24.9 48.6 84.1 825 0.902 21,151 23,010 30.1 7 206 

52 Q2 360.8 18.6 21.3 485.4 593.9 1,702 2.466 88,616 91,282 35.2 0 253 

52 Q3 392.6 15.9 28.2 412.0 623.0 1,945 2.295 118,466 120,921 26.6 0 308 

52 Q4 294.0 15.7 15.9 138.0 558.6 2,174 2.638 108,027 113,484 47.2 0 386 

53 Q1 503.0 21.6 394.6 638.0 648.2 1,066 0.368 73,034 73,941 20.4 0 147 

53 Q2 454.1 32.2 64.1 598.1 692.5 3,601 1.765 70,245 71,294 22.3 0 157 

53 Q3 531.3 38.1 24.6 658.1 704.1 3,834 2.486 78,851 80,226 30.5 0 151 

53 Q4 240.4 21.6 11.5 23.0 494.5 4,901 2.789 73,747 80,294 65.3 0 334 

54 Q1 176.8 19.2 10.1 20.2 110.0 3,279 1.772 51,293 58,698 74.4 0 332 

54 Q2 334.5 46.1 12.4 24.8 590.0 5,629 2.863 64,846 68,572 60.5 0 205 

54 Q3 259.6 30.6 11.2 22.4 441.7 2,915 2.723 48,387 52,439 66.8 0 202 

54 Q4 113.5 12.6 8.5 16.9 25.4 3,062 0.814 43,231 56,410 88.5 55 497 

55 Q1 54.8 3.7 8.6 17.1 25.7 840 0.814 14,964 28,770 87.6 52 525 

55 Q2 116.0 9.4 9.2 18.3 27.5 1,987 0.814 48,008 60,900 81.9 83 525 

55 Q3 91.6 10.3 9.4 18.9 28.3 1,732 0.814 42,831 42,869 79.3 79 468 

55 Q4 111.1 12.6 9.7 19.3 29.0 2,000 0.814 44,150 44,218 77.1 80 398 

56 Q1 67.1 5.6 17.7 24.3 44.0 1,207 0.674 22,629 30,061 71.2 58 448 

56 Q2 54.0 5.1 17.8 21.8 35.0 1,456 0.500 20,628 26,568 57.5 53 492 

56 Q3 82.8 5.0 11.9 35.5 90.8 1,229 1.507 47,537 51,088 40.4 0 617 

56 Q4 155.5 6.2 35.0 103.0 246.5 955 1.447 94,559 96,410 19.5 0 620 

57 Q1 118.7 3.6 60.4 108.5 160.9 654 0.726 67,018 67,066 10.3 0 565 

57 Q2 77.8 4.5 16.5 31.7 94.5 835 1.292 43,388 46,291 29.1 0 595 

57 Q3 82.8 5.3 13.8 28.4 92.7 1,219 1.411 51,771 55,310 32.3 0 668 

57 Q4 40.8 2.3 17.2 21.1 30.7 695 0.433 19,691 27,662 57.2 79 678 

58 Q1 67.3 2.8 21.5 36.2 87.5 660 1.039 43,686 47,379 25.1 0 704 

58 Q2 145.1 5.9 27.7 95.0 213.5 1,920 1.514 98,587 100,699 15.0 0 694 

19 of 81-Appendix 1 
 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-3: Product Limit Estimate Summary Stats for Y-12 Quarterly Gamma Doses, 1952-1979 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

58 Q3 149.5 6.1 47.6 114.4 188.5 1,527 1.021 101,176 103,006 13.5 1 689 

58 Q4 103.5 3.9 24.6 66.3 144.2 1,170 1.311 77,125 81,558 23.9 0 788 

59 Q1 155.1 4.2 68.6 129.0 205.7 1,015 0.815 129,967 130,904 5.2 0 844 

59 Q2 69.9 4.5 15.5 35.2 97.3 2,540 1.363 59,686 59,695 43.9 1 854 

59 Q3 73.7 2.7 19.1 41.4 98.3 645 1.214 63,420 66,993 23.1 0 909 

59 Q4 102.6 3.3 29.1 71.1 139.5 1,290 1.160 103,781 108,038 20.3 0 1,053 

60 Q1 66.5 2.6 13.4 28.1 86.0 1,227 1.378 70,910 76,342 27.8 0 1,148 

60 Q2 88.3 3.3 21.5 57.3 109.4 1,905 1.207 95,706 97,483 11.1 1 1,104 

60 Q3 104.5 2.9 32.9 73.8 152.8 737 1.139 109,523 110,248 4.0 0 1,055 

60 Q4 126.7 3.4 44.2 94.8 179.7 685 1.039 123,400 124,800 7.0 0 985 

61 Q1 21.2 0.8 3.9 10.5 20.1 1,810 1.210 65,293 112,381 78.3 35 5,301 

61 Q2 55.6 0.7 32.2 40.6 57.4 1,276 0.429 306,096 307,190 0.6 267 5,525 

61 Q3 31.3 0.8 10.8 18.6 33.3 2,173 0.836 171,408 171,962 1.0 40 5,494 

61 Q4 61.3 0.7 34.9 46.7 67.1 1,413 0.484 340,995 341,134 0.1 147 5,565 

62 Q1 21.6 0.5 4.9 5.9 20.1 1,050 1.044 120,281 120,593 0.1 52 5,583 

62 Q2 62.0 0.8 32.9 44.6 65.3 1,231 0.509 331,680 331,824 0.0 182 5,352 

62 Q3 52.0 0.8 22.5 40.4 62.6 1,114 0.758 280,127 280,488 0.2 58 5,394 

62 Q4 46.6 0.7 19.5 27.4 52.4 1,018 0.732 247,703 248,238 0.3 46 5,327 

63 Q1 24.7 0.7 2.7 5.4 27.3 1,187 1.721 105,379 134,763 58.3 2 5,456 

63 Q2 26.5 0.6 10.4 15.0 19.5 1,518 0.467 99,473 146,704 56.7 602 5,536 

63 Q3 26.3 0.9 0.9 5.4 25.5 1,315 2.461 108,221 145,939 66.4 0 5,549 

63 Q4 21.6 0.4 10.4 15.7 22.6 447 0.576 49,709 117,958 78.4 187 5,461 

64 Q1 33.8 0.8 20.9 24.2 25.6 757 0.150 72,041 185,123 82.5 897 5,477 

64 Q2 34.7 0.6 23.5 25.5 27.8 1,517 0.126 69,631 184,396 82.7 566 5,314 

64 Q3 41.1 0.7 11.4 23.4 46.5 1,077 1.040 209,747 220,296 13.6 11 5,360 

64 Q4 24.8 0.7 5.3 12.7 23.8 978 1.106 82,049 127,026 72.6 62 5,122 

65 Q1 26.5 0.5 8.1 15.7 30.3 511 0.983 111,109 133,480 35.4 35 5,037 

65 Q2 24.1 0.7 3.9 10.6 22.8 691 1.301 87,080 107,823 41.8 17 4,474 

65 Q3 26.2 0.7 5.7 12.6 24.0 907 1.066 113,778 113,839 0.0 47 4,345 

65 Q4 40.0 0.6 23.6 31.0 38.6 737 0.364 173,468 173,440 0.2 317 4,336 

66 Q1 21.3 0.7 2.4 7.6 19.7 543 1.552 67,798 92,293 61.5 5 4,333 

66 Q2 28.0 0.8 4.9 11.1 24.4 629 1.195 102,181 121,492 41.0 38 4,339 

66 Q3 38.5 0.9 9.1 18.3 37.4 830 1.051 169,574 169,400 0.0 40 4,400 

66 Q4 32.5 1.0 6.1 15.0 26.5 1,900 1.096 122,730 145,762 37.5 71 4,485 

20 of 81-Appendix 1 
 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-3: Product Limit Estimate Summary Stats for Y-12 Quarterly Gamma Doses, 1952-1979 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

67 Q1 25.9 1.3 4.9 10.4 19.9 3,812 1.044 76,794 116,938 76.2 106 4,515 

67 Q2 26.7 1.3 5.1 13.3 23.7 5,000 1.134 98,902 123,167 45.3 51 4,613 

67 Q3 21.7 0.5 5.3 11.0 22.2 751 1.064 98,485 103,140 8.6 26 4,753 

67 Q4 19.2 0.6 4.0 9.0 20.1 1,053 1.199 68,166 92,102 47.3 20 4,797 

68 Q1 18.7 1.5 1.6 5.0 15.5 5,000 1.663 81,812 91,331 23.1 6 4,884 

68 Q2 57.1 0.8 42.4 49.1 61.0 3,670 0.270 283,443 284,015 1.2 186 4,974 

68 Q3 15.2 0.6 4.1 9.9 18.9 751 1.139 22,956 79,222 91.4 16 5,212 

68 Q4 40.2 0.4 24.5 38.5 48.3 528 0.503 212,177 212,779 0.7 112 5,293 

69 Q1 26.3 0.4 12.5 20.5 31.0 668 0.675 134,360 141,967 8.5 76 5,398 

69 Q2 28.0 0.4 11.8 19.7 31.1 392 0.716 147,749 153,048 6.3 92 5,466 

69 Q3 40.4 0.7 13.3 23.5 47.9 786 0.950 234,179 239,774 6.7 43 5,935 

69 Q4 30.4 0.9 10.3 20.6 31.5 3,288 0.832 170,450 178,813 10.1 87 5,882 

70 Q1 32.3 0.6 9.3 20.4 36.1 715 1.002 189,516 194,575 6.2 35 6,024 

70 Q2 15.6 0.2 4.7 10.6 18.8 485 1.024 90,148 93,631 5.4 10 6,002 

70 Q3 39.2 0.8 16.8 29.1 44.9 3,750 0.728 249,184 255,153 5.7 72 6,509 

70 Q4 32.3 0.5 10.5 22.2 33.8 1,197 0.868 196,580 215,506 18.8 93 6,672 

71 Q1 34.0 1.8 17.9 20.9 30.9 11,700 0.405 229,838 229,806 0.2 527 6,759 

71 Q2 13.5 0.3 3.2 7.3 12.3 525 1.003 76,631 91,220 26.0 106 6,757 

71 Q3 34.0 0.4 15.3 27.2 41.1 375 0.730 223,804 225,386 1.3 68 6,629 

71 Q4 22.0 0.4 7.8 14.6 24.4 762 0.846 135,543 144,232 9.7 82 6,556 

72 Q1 21.9 0.4 8.1 14.0 18.4 852 0.611 124,792 142,898 23.4 382 6,525 

72 Q2 17.5 0.4 4.3 10.9 20.1 484 1.150 55,931 112,000 75.3 35 6,400 

72 Q3 14.2 0.5 4.0 9.9 18.8 389 1.149 21,047 90,923 92.4 19 6403 

72 Q4 15.8 0.5 5.1 11.4 19.8 468 1.011 28,924 97,865 89.6 43 6,194 

73 Q1 16.4 0.4 3.4 8.7 17.6 512 1.224 66,793 103,500 58.0 38 6,311 

73 Q2 19.5 0.6 7.1 15.5 23.4 650 0.880 38,983 118,209 88.9 54 6,062 

73 Q3 17.7 0.4 4.3 9.1 17.4 525 1.039 83,297 104,076 35.2 73 5,880 

73 Q4 15.1 0.9 5.4 11.7 21.2 542 1.016 11,442 81,510 96.4 14 5,398 

74 Q1 45.2 0.8 11.6 26.3 56.6 856 1.175 235,519 239,470 5.3 5 5,298 

74 Q2 19.4 0.5 3.4 8.6 19.8 501 1.303 84,142 103,965 39.6 13 5,359 

74 Q3 22.9 0.5 7.6 13.5 22.9 484 0.817 114,266 122,836 13.0 115 5,364 

74 Q4 15.3 0.4 3.3 8.8 18.0 343 1.268 42,413 79,774 70.9 8 5,214 

75 Q1 16.5 0.6 4.9 8.6 15.5 1,420 0.854 74,796 85,272 20.8 110 5,168 

75 Q2 15.1 0.6 3.5 8.7 18.0 972 1.214 26,105 74,247 88.2 16 4,917 

21 of 81-Appendix 1 
 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-3: Product Limit Estimate Summary Stats for Y-12 Quarterly Gamma Doses, 1952-1979 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

75 Q3 12.7 0.6 2.4 8.1 16.6 297 1.422 13,982 56,934 91.3 1 4,483 

75 Q4 11.7 0.5 2.4 6.6 14.1 680 1.316 14,336 53,118 89.4 5 4,540 

76 Q1 16.6 0.4 5.8 10.8 18.0 449 0.844 51,882 76,659 44.7 66 4,618 

76 Q2 13.1 0.4 2.7 6.6 13.7 487 1.191 26,068 60,326 82.7 24 4,605 

76 Q3 19.3 0.4 6.1 11.5 20.0 352 0.877 62,505 88,240 45.9 59 4,572 

76 Q4 13.3 0.7 4.2 9.8 19.1 311 1.127 8,298 62,430 95.2 3 4,694 

77 Q1 11.6 0.3 3.1 6.6 13.2 670 1.086 25,108 57,223 74.2 19 4,933 

77 Q2 11.4 0.3 3.4 7.9 14.9 133 1.093 16,451 57,239 81.2 0 5,021 

77 Q3 18.4 0.5 4.7 10.8 19.7 566 1.070 60,666 93,067 53.9 44 5,058 

77 Q4 9.5 0.3 2.2 4.9 10.4 656 1.145 19,482 46,569 71.9 25 4,902 

78 Q1 9.6 0.3 2.3 4.8 9.4 618 1.046 26,033 48,067 61.3 30 5,007 

78 Q2 15.5 0.4 4.7 9.4 16.8 697 0.937 51,821 78,632 50.0 42 5,073 

78 Q3 41.0 0.5 21.2 31.7 48.1 553 0.606 204,670 213,282 8.3 73 5,202 

78 Q4 9.9 0.3 1.7 4.4 10.8 828 1.358 22,757 52,024 77.4 7 5,255 

79 Q1 9.8 0.3 2.3 5.3 11.4 210 1.185 19,325 50,656 77.1 12 5,169 

79 Q2 12.2 0.3 2.9 7.6 16.3 383 1.286 21,318 67,246 83.4 1 5,512 

79 Q3 17.7 0.6 3.8 10.2 19.1 714 1.203 39,582 91,969 85.6 43 5,196 

79 Q4 16.2 0.5 4.5 9.5 18.5 582 1.043 31,283 88,922 87.5 41 5,489 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

The red solid line in the figure below is the geometric mean (GM) of the prediction density used to 

estimate doses for unmonitored quarters before 1956 (ORAU Technical Report 2004-0888). The 

horizontal blue line segments mark values of 10% of the Radiation Protection Guidelines. The vertical 

green dashed line identifies the first quarter of 1961 when all workers were monitored. As was found 

for the beta doses, there was a distinct drop in the gamma dose distribution once complete monitoring 

was initiated. This drop can be seen in the 25th, 50th, and 75th percentiles in Figure 1a and in the KM 

means in Figure 1b. Maximum doses remained constant in the time periods before and after 1961. 

22 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Figure 1a: Modified Boxplot for Gamma Doses, 1952-1979 

23 of 81-Appendix 1 
 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Figure 1b. Additional Summary Information for Gamma Doses, 1952-1979 

Y-12 Quarterly Gamma Doses 

4.2.2 Modified Boxplots for Beta Dose 

All of the summary statistics used to obtain the modified boxplots for each quarter in Figure 1a are 

listed in Table 4-4 below. Figure 1b gives additional summary information by quarter in separate plots 

for the percent of the quarterly doses that were recorded as zero, the percent of positive outliers, the 

total number of quarterly doses, and the quarterly K-M means. Note that when a lognormal 

distribution is used to describe a quarterly dose distribution, rsdy = [log(xq75) - log(xq25) ] / 1.35 

provides an outlier resistant nonparametric estimate of the standard deviation of log(dose) which is 

equivalent to the log(GSD). 

In Figure 1a the horizontal blue line segments mark values of 10% of the Radiation Protection 

Guidelines, which changed somewhat over this time period. Seventy-five percent of the beta doses 

each quarter were found to be lower than 10% of the Radiation Protection Guidelines except for 1954 

through 1958 when some of the quarterly dose 75th percentiles were slightly larger. Beginning in 

1961, when monitoring was extended to all workers regardless of exposure potential, there was a 

24 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

precipitous drop in the 75th, 50th, and 25th percentiles of dose, which indicated that the newly 

monitored workers generally had doses far lower than the workers who were selected to be monitored 

before 1961. Maximum quarterly doses remained fairly constant from 1953 through 1970, verifying 

that workers with the highest exposure potential were already being monitored before 1961monitored. 

Dose distributions from 1961 and later were highly skewed toward very low doses, pulling the 

boundary for outliers to much lower values, which resulted in additional high outliers. These outliers 

can be seen in the long stretches of black crosses beginning in 1961 when monitoring for all workers 

began. The number of film badge readings that each quarterly box plot was based on, shown in Figure 

1b, was generally about 1000 or less before 1961 and about 5000 or more afterwards. 

Table 4-4: Product Limit Estimate Summary Stats for Y-12 Quarterly Beta Doses, 1952-1979 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

52 Q1 115.0 14.0 10.7 21.3 118.0 1,530 1.783 19,347 23,690 70.4 0 206 

52 Q2 345.2 43.2 10.2 20.4 102.0 3,780 1.707 81,755 87,336 73.5 1 253 

52 Q3 247.7 26.7 9.5 19.1 28.6 2,625 0.814 69,033 76,292 78.6 64 308 

52 Q4 220.1 26.8 9.0 18.0 27.0 2,988 0.814 75,317 84,959 83.4 56 386 

53 Q1 381.1 71.3 9.0 18.1 27.1 4,605 0.814 52,360 56,022 83.0 24 147 

53 Q2 334.8 62.3 8.9 17.8 26.8 3,712 0.814 48,604 52,564 84.1 25 157 

53 Q3 418.9 57.2 11.0 22.0 436.2 2,750 2.729 60,160 63,254 68.2 0 151 

53 Q4 413.3 31.0 21.8 291.1 510.8 3,989 2.339 134,586 138,042 34.4 0 334 

54 Q1 411.3 40.4 29.3 227.4 294.5 4,615 1.711 133,986 136,552 25.6 0 332 

54 Q2 717.6 77.8 19.0 266.5 841.3 6,961 2.811 144,686 147,108 39.5 0 205 

54 Q3 771.0 72.3 20.5 585.0 898.0 5,892 2.803 153,518 155,742 36.6 0 202 

54 Q4 968.3 45.6 247.9 613.8 1,318.0 5,311 1.238 479,014 481,245 15.1 0 497 

55 Q1 986.3 42.8 399.6 655.5 1,132.5 7,046 0.772 516,922 517,808 5.7 3 525 

55 Q2 816.5 32.7 197.1 723.9 978.7 5,065 1.188 426,285 428,662 15.0 0 525 

55 Q3 629.0 32.5 238.4 494.0 657.0 4,439 0.751 291,540 294,372 20.1 8 468 

55 Q4 1,102.9 63.0 499.5 815.0 1,242.0 8,522 0.675 438,953 438,954 20.4 12 398 

56 Q1 861.5 33.7 426.0 651.0 1,038.0 4,470 0.660 385,636 385,952 4.5 1 448 

56 Q2 681.8 32.5 195.0 447.0 832.0 3,828 1.075 335,407 335,446 0.2 0 492 

56 Q3 745.3 28.0 319.8 495.0 917.0 4,419 0.781 459,847 459,850 0.2 0 617 

56 Q4 557.1 25.3 216.0 338.0 600.0 5,234 0.757 345,393 345,402 0.3 12 620 

57 Q1 975.2 37.9 471.9 688.5 1,098.8 9,524 0.627 550,937 550,988 0.4 7 565 

57 Q2 682.1 25.3 234.9 432.0 921.0 3,393 1.013 405,847 405,850 0.2 0 595 

57 Q3 517.0 20.6 193.1 299.0 664.0 3,621 0.916 345,365 345,356 0.1 0 668 

57 Q4 475.1 17.1 194.7 303.5 569.4 3,028 0.796 322,130 322,118 0.0 1 678 

58 Q1 465.9 16.2 194.7 282.0 619.0 3,017 0.858 327,976 327,994 0.0 0 704 

58 Q2 322.4 15.3 66.5 198.0 408.0 3,674 1.345 223,153 223,746 4.8 0 694 

58 Q3 413.7 15.0 154.5 307.0 549.9 3,084 0.941 284,655 285,039 3.2 0 689 

25 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-4: Product Limit Estimate Summary Stats for Y-12 Quarterly Beta Doses, 1952-1979 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

58 Q4 318.0 11.8 61.2 204.5 470.0 2,755 1.511 249,632 250,584 7.9 0 788 

59 Q1 289.7 10.8 54.2 182.0 422.0 2,245 1.521 242,922 244,507 9.2 0 844 

59 Q2 304.1 11.4 64.8 201.0 425.5 2,532 1.395 259,124 259,701 4.4 0 854 

59 Q3 369.6 18.8 57.6 203.6 471.0 5,956 1.558 334,555 335,966 8.9 0 909 

59 Q4 373.4 18.7 45.9 177.5 485.8 10,407 1.749 391,002 393,190 12.3 0 1,053 

60 Q1 279.7 12.6 32.0 108.0 354.0 5,109 1.782 319,784 321,096 6.0 0 1,148 

60 Q2 391.6 17.7 44.8 165.3 468.0 5,910 1.739 431,590 432,326 3.9 0 1,104 

60 Q3 464.6 18.9 55.4 230.8 590.3 3,840 1.753 489,680 490,153 2.7 0 1,055 

60 Q4 398.5 17.2 49.4 177.5 518.2 3,628 1.742 392,300 392,522 1.4 0 985 

61 Q1 125.0 4.0 11.3 22.9 86.8 4,475 1.512 625,940 662,625 45.8 29 5,301 

61 Q2 112.9 4.0 4.9 14.0 58.0 4,379 1.828 600,191 623,772 39.8 17 5,525 

61 Q3 101.4 3.3 7.5 15.4 59.5 4,069 1.531 550,282 557,092 10.9 41 5,494 

61 Q4 94.1 3.4 5.6 13.8 51.6 4,534 1.651 495,874 523,666 46.4 42 5,565 

62 Q1 92.2 2.9 7.8 18.3 63.8 2,555 1.560 494,696 514,753 30.0 28 5,583 

62 Q2 136.6 4.8 10.6 24.2 78.9 4,266 1.490 717,376 731,083 19.5 87 5,352 

62 Q3 112.7 3.5 15.9 24.4 64.2 2,986 1.036 567,228 607,904 43.5 343 5,394 

62 Q4 84.8 3.1 12.4 21.9 28.6 3,700 0.618 392,191 451,730 68.0 793 5,327 

63 Q1 80.6 3.0 17.3 24.3 36.4 4,800 0.550 374,051 439,754 62.0 736 5,456 

63 Q2 70.7 2.6 1.8 9.4 30.8 2,519 2.108 363,997 391,395 59.3 4 5,536 

63 Q3 95.4 3.4 17.2 23.6 56.7 5,825 0.886 485,017 529,375 42.3 380 5,549 

63 Q4 66.8 2.2 9.9 18.1 47.3 3,047 1.161 329,266 364,795 48.2 122 5,461 

64 Q1 73.3 2.5 14.1 19.2 40.2 40,54 0 .777 350,941 401,464 58.3 484 5,477 

64 Q2 83.9 2.6 18.2 24.5 60.7 3,368 0.891 399,539 445,845 43.9 249 5,314 

64 Q3 91.7 3.1 16.2 27.1 51.1 3,034 0.853 482,032 491,512 10.6 417 5,360 

64 Q4 76.6 3.4 11.0 16.9 26.1 3,810 0.644 329,985 392,345 78.1 633 5,122 

65 Q1 58.8 2.0 7.4 15.8 27.7 3,424 0.976 252,975 296,176 62.3 379 5,037 

65 Q2 61.3 2.5 8.7 15.6 36.4 2,924 1.056 258,853 274,256 27.6 197 4,474 

65 Q3 51.9 2.6 6.4 12.8 26.6 5,290 1.059 209,635 225,506 29.6 223 4,345 

65 Q4 43.3 1.8 9.1 16.5 25.4 2,726 0.756 144,097 187,749 68.9 317 4,336 

66 Q1 64.3 2.9 10.5 20.5 41.4 5,290 1.019 269,756 278,612 13.8 158 4,333 

66 Q2 63.2 2.8 9.1 18.6 35.6 5,290 1.012 260,308 274,225 23.7 223 4,339 

66 Q3 72.2 3.2 10.5 21.6 50.8 5,290 1.173 297,393 317,680 32.1 95 4,400 

66 Q4 63.5 2.2 10.0 23.0 39.4 1,894 1.017 270,808 284,798 19.4 192 4,485 

67 Q1 57.8 2.4 11.1 16.9 38.9 5,290 0.929 237,292 260,967 37.9 203 4,515 

26 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-4: Product Limit Estimate Summary Stats for Y-12 Quarterly Beta Doses, 1952-1979 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

67 Q2 64.3 2.6 9.5 19.9 43.4 5,290 1.127 279,823 296,616 25.7 139 4,613 

67 Q3 42.0 1.9 5.3 12.2 25.0 5,290 1.142 161,328 199,626 67.9 174 4,753 

67 Q4 50.8 2.0 6.2 15.2 31.4 5,290 1.202 219,480 243,688 42.4 143 4,797 

68 Q1 55.0 2.6 5.7 13.5 27.8 5,290 1.180 239,455 268,620 52.3 200 4,884 

68 Q2 28.6 1.5 5.4 10.6 20.7 5,290 0.995 100,474 142,256 74.9 183 4,974 

68 Q3 48.1 1.7 7.9 16.0 27.3 2,663 0.916 196,730 250,697 73.8 336 5,212 

68 Q4 49.8 1.8 7.9 15.6 26.4 2,932 0.896 206,283 263,591 74.9 394 5,293 

69 Q1 36.1 1.2 5.9 13.6 24.3 1,162 1.046 142,308 194,868 75.7 245 5,398 

69 Q2 37.7 1.7 6.0 11.8 22.5 3,986 0.977 168,895 206,068 58.1 280 5,466 

69 Q3 31.7 1.8 4.1 9.9 19.4 5,290 1.148 135,328 188,140 80.9 196 5,935 

69 Q4 30.8 1.8 2.8 8.7 15.4 4,660 1.264 148,342 181,166 64.1 187 5,882 

70 Q1 40.3 2.9 3.1 7.2 17.5 8,120 1.283 202,042 242,767 76.5 213 6,024 

70 Q2 18.7 0.7 3.0 7.2 15.1 1,514 1.202 82,310 112,237 57.9 96 6,002 

70 Q3 47.1 2.5 5.4 11.4 20.1 7,200 0.982 250,084 306,574 77.7 474 6,509 

70 Q4 54.3 2.5 4.6 13.1 24.4 5492 1.238 317,080 362,290 57.7 297 6,672 

71 Q1 31.9 1.4 5.6 11.5 21.2 1,961 0.987 137,896 215,612 90.7 303 6,759 

71 Q2 29.2 1.0 3.9 7.9 17.0 1,647 1.102 161,979 197,304 53.9 301 6,757 

71 Q3 18.6 0.9 3.7 7.1 15.4 1,462 1.060 64,122 123,299 92.8 172 6,629 

71 Q4 19.0 0.8 3.0 5.6 13.3 1,354 1.112 84,144 124,564 78.2 217 6,556 

72 Q1 26.0 1.4 2.8 6.6 15.3 3,675 1.257 134,384 169,650 65.9 182 6,525 

72 Q2 43.1 1.3 6.6 14.6 26.3 3,330 1.021 227,823 275,840 60.0 305 6,400 

72 Q3 29.3 0.9 7.6 15.7 24.3 1,071 0.862 106,216 187,608 86.0 254 6,403 

72 Q4 33.4 1.1 7.4 14.3 25.4 1,151 0.920 133,502 206,880 83.2 291 6,194 

73 Q1 31.9 1.0 6.1 13.5 21.9 1,019 0.943 134,159 201,321 83.5 308 6,311 

73 Q2 35.9 1.4 9.2 16.1 23.9 2,542 0.710 140,266 217,626 85.1 356 6,062 

73 Q3 26.3 1.0 4.7 10.9 21.9 1,872 1.134 93,431 154,644 85.8 129 5,880 

73 Q4 24.7 1.1 6.9 14.0 20.6 1,158 0.811 62,573 133,331 92.1 190 5,398 

74 Q1 41.7 2.0 5.6 13.0 22.6 2,210 1.037 155,407 220,927 89.6 252 5,298 

74 Q2 34.2 1.3 6.0 14.3 23.5 1,350 1.005 124,507 183,278 82.0 230 5,359 

74 Q3 29.1 1.1 6.2 13.5 21.4 1,231 0.922 96,214 156,092 84.9 221 5,364 

74 Q4 27.8 1.2 5.9 13.5 23.1 2,145 1.018 81,935 144,949 88.6 162 5,214 

75 Q1 34.1 1.2 5.6 14.4 25.1 1,281 1.118 122,052 176,229 79.8 123 5,168 

75 Q2 36.8 1.3 5.1 12.7 24.0 1,207 1.148 138,448 180,946 72.9 133 4,917 

75 Q3 30.8 1.2 4.9 11.9 24.5 1,953 1.189 101,723 138,076 70.7 67 4,483 

27 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-4: Product Limit Estimate Summary Stats for Y-12 Quarterly Beta Doses, 1952-1979 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

75 Q4 32.2 1.1 4.8 12.0 24.6 1,624 1.217 112,104 146,188 66.2 67 4,540 

76 Q1 51.6 1.1 24.3 38.5 47.7 1,730 0.501 235,526 238,289 4.4 273 4,618 

76 Q2 22.1 1.0 4.5 11.2 20.4 1,655 1.125 67,747 101,770 66.3 54 4,605 

76 Q3 24.9 1.1 4.0 9.1 17.0 1,555 1.079 86,799 113,843 59.4 134 4,572 

76 Q4 25.8 1.1 6.2 14.5 22.4 1,670 0.950 66,632 121,105 84.5 108 4,694 

77 Q1 20.4 0.8 3.4 8.5 17.8 1,206 1.221 68,629 100,633 65.9 56 4,933 

77 Q2 15.3 0.4 4.3 9.5 18.2 1,553 1.062 45,505 76,821 59.4 1 5,021 

77 Q3 28.7 1.2 6.2 11.7 19.9 2,300 0.861 120,537 145,165 43.0 251 5,058 

77 Q4 21.7 0.9 3.1 7.3 16.9 1,383 1.246 78,504 106,373 62.0 63 4,902 

78 Q1 26.2 1.0 4.4 10.2 19.2 1,433 1.096 109,993 131,183 40.7 132 5,007 

78 Q2 27.6 1.2 3.5 8.5 18.5 1,673 1.245 116,223 140,015 50.2 110 5,073 

78 Q3 27.7 1.4 4.8 10.7 19.0 1,708 1.022 90,346 144,095 89.0 169 5,202 

78 Q4 25.9 1.1 3.7 9.1 20.7 1,660 1.287 107,413 136,104 55.9 56 5,255 

79 Q1 30.0 1.0 5.6 12.8 23.5 1,638 1.064 123,970 155,070 51.9 110 5,169 

79 Q2 41.9 1.2 7.7 17.7 34.9 1,587 1.119 214,347 230,953 23.2 90 5,512 

79 Q3 27.7 1.1 5.9 11.8 21.8 1,621 0.969 99,901 143,929 70.4 151 5,196 

79 Q4 39.6 1.5 5.9 13.7 24.9 1,622 1.072 177,670 217,364 59.0 183 5,489 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

The red solid line seen in Figure 2a is the GM of the prediction density used to estimate doses for 

unmonitored quarters before 1956. The horizontal blue line segments mark values of 10% of the 

Radiation Protection Guidelines. The vertical green dashed line identifies the first quarter of 1961 

when all workers were monitored. When complete monitoring began, the dose distributions dropped 

dramatically. Workers with higher exposure potential, who had been monitored previously, were 

joined after 1961 by workers with lower exposure workers added to the monitoring program. In 

department 2619, for example, the dose distribution fell in 1961 and remained low, although 

maximum quarterly doses were fairly constant for several years. Higher doses workers who had 

previously been monitored became outliers in the lower dose distribution. 

28 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028
 

Figure 2a. Modified Boxplot for Beta Doses, 1952-1979 

29 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Figure 2b. Additional Summary Information for Beta Doses, 1952-1979 

4.3 Analysis by Departments 

To compare the change in average dose by department in the years after all workers began to be 

monitored to the immediately proceeding years, the summary statistics that follow were calculated by 

department for all beta and gamma doses during this period. 

4.3.1 Departmental Gamma Doses 

The following table is partitioned into three parts. Departments in Part A and Part B were determined 

by whether the mean dose in 1961 through 1965 was less than or greater than 60 mrem, which was 

one percent of the quarterly Radiation Protection Guidelines for beta dose. Departments in Part C 

30 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

were in the process of being closed out in 1960 or 1961. After complete monitoring began in 1961, the 

highest quarterly mean dose accrued by workers in department 2722 was 107.8 mrem. This can be 

compared to the quarterly Radiation Protection Guidelines values of 3,000 mrem in 1960 and 1,250 

mrem today. Although individuals may have had higher doses, workers with high dose potential were 

carefully monitored to be sure that they did not exceed the Radiation Protection Guidelines. 

Table 4-5A: Y-12 Gamma Doses Ordered by Adjusted Mean Dose, 1961-1965 

Part A. Departments with quarterly gamma mean for 1961-1965 less than 30 mrem (MDL) 

Dept. NW 

56-601 

NM 

56-602 

M% 

56-603 

Mean 

56-604 

A Mean 

61-655 

Mean 

61-656 

N 

61-657 

2051 182 0 0.0 NA 16.9 8.3 155 

2137 118 0 0.0 NA 17.8 11.7 103 

2073 360 0 0.0 NA 18.0 12.5 303 

2157 151 0 0.0 NA 18.0 12.4 353 

2301 1,715 215 12.5 65.0 18.0 11.0 44 

2102 99 0 0.0 NA 18.2 13.5 96 

2065 349 0 0.0 NA 18.7 13.1 633 

2060 303 0 0.0 NA 18.8 13.0 493 

2090 613 20 3.3 15.9 18.8 13.3 539 

2141 176 0 0.0 NA 18.8 12.9 163 

2146 630 0 0.0 NA 19.0 12.9 821 

2046 269 0 0.0 NA 19.2 12.6 247 

2098 52 0 0.0 NA 19.2 11.8 65 

2115 70 0 0.0 NA 19.2 12.9 116 

2068 594 0 0.0 NA 19.3 14.0 614 

2101 90 0 0.0 NA 19.3 13.3 74 

2133 196 0 0.0 NA 19.9 13.6 125 

2067 569 0 0.0 NA 20.1 13.9 586 

2017 269 2 0.7 0.0 20.2 14.1 242 

2002 430 0 0.0 NA 20.3 14.0 208 

2069 245 0 0.0 NA 20.3 14.8 472 

2163 273 0 0.0 NA 20.6 14.9 275 

2148 275 0 0.0 NA 20.8 16.8 68 

2140 246 0 0.0 NA 21.0 14.3 148 

2093 511 491 96.1 14.4 21.3 15.7 464 

2107 433 0 0.0 NA 21.5 15.2 373 

2149 7 0 0.0 NA 21.5 16.0 424 

2139 353 0 0.0 NA 22.0 16.7 300 

2041 180 0 0.0 NA 22.1 17.3 160 

2142 1,695 1 0.1 0.0 22.1 16.0 1,917 

2094 170 0 0.0 NA 22.3 16.2 150 

2096 436 0 0.0 NA 22.5 16.7 233 

2151 692 0 0.0 NA 22.5 17.9 359 

2091 2,679 85 3.2 11.9 22.7 17.5 2,022 

2085 77 0 0.0 NA 22.8 17.6 63 

2014 5,215 8 0.2 80.0 23.0 17.2 4,110 

2057 595 0 0.0 NA 23.0 17.2 793 

2001 2,252 2 0.1 0.0 23.1 17.2 2,254 

2136 51 0 0.0 NA 23.1 16.9 69 

2346 54 3 5.6 22.0 23.1 18.3 358 

2066 501 0 0.0 NA 23.2 17.7 744 

2743 433 0 0.0 NA 23.2 17.6 284 

31 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-5A: Y-12 Gamma Doses Ordered by Adjusted Mean Dose, 1961-1965 

Part A. Departments with quarterly gamma mean for 1961-1965 less than 30 mrem (MDL) 

Dept. NW 

56-601 

NM 

56-602 

M% 

56-603 

Mean 

56-604 

A Mean 

61-655 

Mean 

61-656 

N 

61-657 

2742 727 0 0.0 NA 23.5 17.2 1,152 

2015 4,791 2 0.0 0.0 23.7 17.4 4,127 

2695 608 0 0.0 NA 23.7 17.3 2,038 

2345 80 32 40.0 19.8 24.0 18.7 810 

2070 944 0 0.0 NA 24.2 18.6 1,101 

2100 52 0 0.0 NA 24.3 20.6 14 

2700 268 0 0.0 NA 24.4 18.2 443 

2059 210 0 0.0 NA 24.6 20.0 322 

2143 904 1 0.1 0.0 24.7 18.8 784 

2200 406 50 12.3 15.7 24.7 18.5 735 

2058 328 0 0.0 NA 24.9 21.2 32 

2006 346 0 0.0 NA 25.1 19.8 288 

2342 45 0 0.0 NA 25.1 19.8 574 

2664 219 0 0.0 NA 25.1 19.4 98 

2665 1,188 657 55.3 78.5 25.1 19.5 597 

2145 754 0 0.0 NA 25.2 21.1 125 

2077 4,008 219 5.5 29.6 25.3 19.4 2,665 

2095 59 0 0.0 NA 25.5 20.6 27 

2616 2,298 40 1.7 26.5 26.4 21.5 1,187 

2685 2,265 3 0.1 12.7 26.5 26.5 119 

2011 184 0 0.0 NA 26.6 24.8 79 

2687 2,081 12 0.6 46.1 27.1 20.8 2,023 

2343 64 0 0.0 NA 27.2 21.8 619 

2216 614 1 0.2 0.0 28.3 24.0 472 

2071 394 0 0.0 NA 28.5 26.7 421 

2161 250 0 0.0 NA 28.5 24.4 367 

2144 357 0 0.0 NA 29.0 25.9 82 

2260 386 7 1.8 18.6 29.1 25.8 112 

2044 531 304 57.3 156.9 30.0 25.0 212 

2682 1,319 0 0.0 NA 30.5 27.1 408 

2009 92 0 0.0 NA 30.6 28.2 34 

2204 148 124 83.8 37.1 31.2 25.2 233 

2158 4,352 125 2.9 99.6 31.8 27.4 4,139 

2230 1,270 125 9.8 11.5 33.2 29.3 226 

Notes: 

1

 Number of quarters worked, 1956-1960 

2

 Number of quarters monitored, 1956-1960 

3

 Percent of worked quarters that were monitored, 1956-1960 4 Mean dose, 1956-1960 

5

 Mean dose adjusted for zeros by left-censoring methods, 1961-1965 

6

 Mean dose with zeros, 1961-1965 

7

 Number of quarterly doses, 1961-1965 

Table 4-5B: Y-12 Gamma Doses Ordered by Adjusted Mean Dose, 1961-1965 

Part B. Departments with quarterly gamma mean for 1961-1965 greater than 30 mrem 

Dept. NW 

56-601 

NM 

56-602 

M% 

56-603 

Mean 

56-604 

A Mean 

61-655 

Mean 

61-656 

N 

61-657 

2128 571 209 36.6 59.4 33.9 30.3 246 

32 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-5B: Y-12 Gamma Doses Ordered by Adjusted Mean Dose, 1961-1965 

Part B. Departments with quarterly gamma mean for 1961-1965 greater than 30 mrem 

Dept. NW 

56-601 

NM 

56-602 

M% 

56-603 

Mean 

56-604 

A Mean 

61-655 

Mean 

61-656 

N 

61-657 

2257 860 0 0.0 NA 34.8 30.5 201 

2344 81 30 37.0 72.8 35.8 30.9 910 

2003 7,535 110 1.5 31.3 35.9 33.8 2,862 

2018 5,153 27 0.5 29.6 35.9 30.8 6,105 

2164 36 0 0.0 NA 37.2 37.2 174 

2038 379 0 0.0 NA 39.9 38.1 756 

2703 5,218 4,636 88.8 72.4 43.5 40.2 2,332 

2638 683 52 7.6 155.3 44.3 40.8 395 

2637 247 0 0.0 NA 47.1 43.0 1,454 

2055 33 2 6.1 0.0 48.1 46.7 1,403 

2701 1,639 1,459 89.0 145.0 49.6 46.2 2,399 

2793 820 786 95.9 92.6 50.5 48.2 677 

2162 50 18 36.0 17.1 51.1 47.6 246 

2108 572 122 21.3 65.4 53.9 52.3 304 

2618 1,551 1,077 69.4 110.4 57.5 54.4 1,912 

2233 1,636 844 51.6 59.0 74.8 73.3 783 

2617 3,761 878 23.3 69.0 76.6 75.0 3,427 

2619 3,258 365 11.2 149.6 77.0 75.0 1,943 

2259 409 305 74.6 127.5 80.9 79.0 305 

2702 738 717 97.2 280.2 83.2 81.5 1,038 

2776 1,187 106 8.9 20.6 91.7 90.7 866 

2718 65 0 0.0 NA 92.6 90.3 43 

2722 257 251 97.7 183.5 108.5 107.8 545 

Notes: 

1

 Number of quarters worked, 1956-1960 

2

 Number of quarters monitored, 1956-1960 

3

 Percent of worked quarters that were monitored, 1956-1960 4 Mean dose, 1956-1960 

5

 Mean dose adjusted for zeros by left-censoring methods, 1961-1965 

6

 Mean dose with zeros, 1961-1965 

7

 Number of quarterly doses, 1961-1965 

Table 4-5C: Y-12 Gamma Doses Ordered by Adjusted Mean Dose, 1961-1965 

Part C. Quarterly gamma dose statistics for departments no longer operating after 1960 

Dept. NW 

56-601 

NM 

56-602 

M% 

56-603 

Mean 

56-604 

A Mean 

61-655 

Mean 

61-656 

N 

61-657 

2026 88 0 0.0 NA NA NA 0 

2056 185 0 0.0 NA NA NA 0 

2088 32 0 0.0 NA NA NA 0 

2159 1,723 32 1.9 62.4 NA NA 0 

2160 106 2 1.9 105.0 NA NA 0 

2205 60 53 88.3 18.6 NA NA 0 

2231 743 159 21.4 156.1 NA 25.0 2 

2681 1,069 0 0.0 NA NA 7.0 2 

2683 749 0 0.0 NA NA NA 0 

2690 111 0 0.0 NA NA NA 0 

2692 182 3 1.6 109.3 NA NA 0 

2791 1,333 208 15.6 109.7 NA NA 0 

33 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-5C: Y-12 Gamma Doses Ordered by Adjusted Mean Dose, 1961-1965 

Part C. Quarterly gamma dose statistics for departments no longer operating after 1960 

Dept. NW 

56-601 

NM 

56-602 

M% 

56-603 

Mean 

56-604 

A Mean 

61-655 

Mean 

61-656 

N 

61-657 

2792 714 528 73.9 29.0 NA NA 0 

2799 65 0 0.0 NA NA NA 0 

Notes: 

1

 Number of quarters worked, 1956-1960 

2

 Number of quarters monitored, 1956-1960 

3

 Percent of worked quarters that were monitored, 1956-1960 4 Mean dose, 1956-1960 

5

 Mean dose adjusted for zeros by left-censoring methods, 1961-1965 

6

 Mean dose with zeros, 1961-1965 

7

 Number of quarterly doses, 1961-1965 

4.3.2 Departmental Beta Doses 

There were 426,621 beta doses recorded for Y-12 workers from 1952 to 1979 including non-detects 

recorded as zeros. Before 1961 there were 101,139 quarterly records, which included 15,508 (15.3%) 

monitoring records and an additional 85,631 working quarters that were not monitored. Unmonitored 

quarters were obtained from a file of Y-12 work history records that included job start date, job 

termination date, job title and department for each worker and each change of job title. 

Table 4-6 presents the summary statistics listed above for beta doses for each Y-12 departments in 

operation during this time period, ordered from smallest to largest adjusted mean dose for 1961-65. 

Changes in the number of working quarters, reflecting the number of workers assigned to a 

department, can be found in Table 4-6 by comparing values in column NW56-60 to the column N61­

65. To provide an indication of the consistency of the workers assigned to a department, the %same 

column gives the percent of workers assigned to a department in 1961 who were also in that 

department in 1960. Departments where %same is absent had no assigned workers in 1961. The 

%same would inevitably be lowered for departments who had large increases or decreases in the 

number of workers as projects ended or began. Note that even with some change in department 

personnel, the exposure potential would remain similar when the activity, machining for example, was 

the same. 

The following table, Table 4-6, is partitioned into three parts. Departments in Part A and Part B were 

determined by whether the mean dose in 1961 through 1965 was less than or greater than 60 mrem, 

which was one percent of the quarterly Radiation Protection Guidelines for beta dose. Departments in 

Part C were in the process of being closed out in 1960 or 1961. Among the 83 departments in Part A, 

in which beta dose potential was extremely low, two points are evident: (1) in the majority of these 

departments very few working quarters were monitored (63 of these departments had less than one 

percent monitoring), and (2) individuals who were selected for monitoring before 1961 generally were 

exposed to beta particles since means for 1956 through 1960 when monitoring occurred were 

generally greater than 100 mrem. These two points provide solid evidence that workers not being 

monitored before 1961 had low potential for beta-particle exposure. 

Working in the 17 departments in Part B may have provided higher potential of beta-particle 

exposure. Five of these departments (2055, 2162, 2164, 2637, and 2718) were not initiated until late 

1960 or early 1961. Department 2233 ceased to exist after 1961 and was growing smaller in 1961, and 

department 2638 had no assigned workers in 1961. Mean dose for 1961-65 in department 2776 was 

less than three percent of Radiation Protection Guidelines. Among the remaining departments in Part 

34 of 81-Appendix 1 
 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

B, the following points are apparent: (1) 70% or more of the working quarters were selected for 

monitoring in 1956 through 1960, and (2) mean dose from 1956-60 was greater than the mean in 

1961-65 except for department 2618, which was about 15% lower. Only in departments 2701 before 

1961 and 2722 and 2618 before and after 1961 were mean doses at least 10% of the Radiation 

Protection Guidelines, which was the level at which monitoring was required. These departments had 

approximately 90%, 98%, and 70% of working quarters monitored in 1956 through 1960. 

The mean beta dose assigned to unmonitored quarters before 1960 based on regression methods is 

about 500 mrem. Therefore, only in department 2618 may a worker have had an unmonitored quarter 

in which the assigned doses would likely be below the mean for 1961 through 1965. If "scaling" based 

on doses after 1960 is applied to assigned doses for unmonitored quarters as was done for gamma 

doses, this would most likely adjust the assigned doses upward for workers with 

higher exposure potential (ORAUT-PROC-0042). 

All of the 14 departments in Part C were being closed down during 1960, and eight of them had fewer 

than 200 working quarters during the five years of 1956 through 1960. In departments 2792 and 

2205 three-fourths or more of the working quarters were monitored before 1961. Only 12 individuals 

were assigned to department 2159 in 1960, and after 1959 these tradesmen were already being 

transferred to other departments before blanket monitoring was planned. Workers in department 2231 

were engaged in laboratory work with little potential exposure to external radiation. The higher mean 

doses from 1956 through 1960 for departments 2791 and 2793, which were engaged in similar tasks, 

demonstrate that the workers with exposure potential were being selected for monitoring. 

Table 4-6B: Y-12 Beta Doses 1956-1965 Order by Adjusted Mean Dose, 1956-1960 

Part B. Departments where quarterly beta mean for 1961-1965 was greater than 60 mrem 

Dept. NW 

56-601 

NM 

56-602 

M 

56-60 

(%)3 

Mean 

56-604 

A Mean 

615 

Mean 

61-656 

N 

61-657 

2164 36 0 0 NA 73.3 68.3 174 

2718 65 0 0 NA 75.2 72.9 43 

2619 3,258 365 11.2 746.9 90 84.6 1,943 

2637 247 0 0 NA 100.4 94.6 1,454 

2664 219 0 0 NA 125.5 123.4 98 

2776 1,187 106 8.9 412.3 148.2 146.6 866 

2259 409 305 74.6 291.7 176.8 175.1 305 

2162 50 18 36 49.2 200.8 199 246 

2793 820 786 95.9 347.1 213.9 212.6 677 

2701 1,639 1,459 89 502.5 223.7 221.8 2,399 

2638 683 52 7.6 105.5 244.7 241.3 395 

2055 33 2 6.1 257 275.7 275 1,403 

2703 5,218 4,636 88.8 467.1 318.3 317.3 2,332 

2702 738 717 97.2 1,200.6 441 440.1 1,038 

2233 1,636 844 51.6 283.4 466.1 465 783 

2722 257 251 97.7 677.6 500.7 500.3 545 

Notes: 

1

 Number of quarters worked, 1956-1960 

2

 Number of quarters monitored, 1956-1960 

3

 Percent of worked quarters that were monitored, 1956-1960 4 Mean dose, 1956-1960 

5

 Mean dose adjusted for zeros by left-censoring methods, 1961-1965 

6

 Mean dose with zeros, 1961-1965 

7

 Number of quarterly doses, 1961-1965 

35 of 81-Appendix 1 
 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-6C: Y-12 Beta Doses 1956-1965 Order by Adjusted mean dose, 1956-1960 

Part C. Beta dose statistics for departments no longer operating after 1960 

Dept. NW 

56-601 

NM 

56-602 

M 

56-60 

(%)3 

Mean 

56-604 

A Mean 

615 

Mean 

61-656 

N 

61-657 

2026 88 0 0.0 NA NA NA 0 

2056 185 0 0.0 NA NA NA 0 

2088 32 0 0.0 NA NA NA 0 

2159 1723 32 1.9 97.1 NA NA 0 

2160 106 2 1.9 0.0 NA NA 0 

2205 60 53 88.3 199.8 NA NA 0 

2231 743 159 21.4 569.8 NA 5.0 2 

2681 1,069 0 0.0 NA NA 1.0 2 

2683 749 0 0.0 NA NA NA 0 

2690 111 0 0.0 NA NA NA 0 

2692 182 3 1.6 309.7 NA NA 0 

2791 1,333 208 15.6 1030.1 NA NA 0 

2792 714 528 73.9 677.2 NA NA 0 

2799 65 0 0.0 NA NA NA 0 

Notes: 

1

 Number of quarters worked, 1956-1960 

2

 Number of quarters monitored, 1956-1960 

3

 Percent of worked quarters that were monitored, 1956-1960 4 Mean dose, 1956-1960 

5

 Mean dose adjusted for zeros by left-censoring methods, 1961-1965 

6

 Mean dose with zeros, 1961-1965 

7

 Number of quarterly doses, 1961-1965 

4.4 Comparing 1961 Gamma Dose Distributions of Workers Monitored Versus 

Not Monitored in 1960 

In 1961 the Y-12 facility adopted a policy that required monitoring all workers for external radiation 

exposure. Before this time the Y-12 policy was to select workers for external monitoring if they had 

potential for exposure to 10 percent or more of the Radiation Protection Guidelines. An assessment of 

the 1961 gamma doses to appraise whether workers with higher exposure potential had indeed been 

selected to be monitored before 1961 is presented below. Since workers monitored before 1961 were 

picked because of higher dose potential, the distribution of the doses in 1961 for previously monitored 

individuals should be higher than the distribution of doses for workers who were first monitored in 

1961. Therefore, the 1961 doses were separated into two groups partitioned by each worker’s 

monitoring status in 1960. “Group 1” consisted of 1961 workers who were chosen to be monitored in 

1960, and “Group 2” included those employees who were not monitored in 1960. 

Figure 3 provides an initial look at the1961 third and fourth quarter gamma doses of the two groups of 

workers. Because Group 2 was approximately four times the size of Group 1, histograms based on 

percents rather than counts were used to facilitate a comparison of doses for the two groups. The top 

two graphs (Group 1) show relatively fewer doses in the lower dose range and distinctly more doses 

above 100 mrem than the corresponding Group 2 doses below. The statistics above each plot were 

based on a lognormal model with EX indicating the expected value of the doses, SDX the standard 

deviation, GM the geometric mean, and GSD the geometric standard deviation. The indicated 

parameters derived from each the lognormal models are the natural logarithms of the geometric mean 

36 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

and geometric standard deviation. These statistics further verify that the average doses were higher for 

workers who had been selected for monitoring in 1960. 

Figure 3. Histograms for Y-12 Quarterly Gamma Doses in 1961 for Two Groups of Workers 

Partitioned by Monitoring Status in 1960 

Statistics for 1961 quarterly gamma doses are presented in Table 4-7 for the two groups of Y-12 

workers. The percentiles, Kaplan-Meier means, and adjusted cumulative doses were calculated taking 

into account doses recorded as zero, which indicated film badge readings below the minimum 

detectible level (MDL). These statistics were derived using non-parametric left-censored methods 

with the non-detectible doses (recorded as zero) designated to have an upper limit of 30 mrem. 

Because there were very few zero doses in quarters two (Q2), three (Q3), and four (Q4) of 1961, the 

left-censored methods had little impact on the calculated statistics, as can be seen by comparing the 

directly calculated cumulative doses to the adjusted cumulative doses in Table 4-7. However, in the 

first quarter (Q1) of 1961 the percents of non-detectible doses were 53 and 86 for the previously 

monitored and newly monitored groups, respectively, which substantially increased the adjusted 

cumulative doses, percentiles, and Kaplan-Meier means, particularly for Group 2. In every quarter of 

1961 the 25th, 50th (median), and 75th percentiles for Group 1 workers were higher than those for 

Group 2. Further, except for Q1, medians for previously monitored individuals were higher than the 

37 of 81-Appendix 1 
 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

75th percentiles for the newly monitored, verifying that workers who were selected to be monitored in 

1960 had higher exposure potential. 

A modified version of a boxplot was used to summarize the gamma-ray doses for the two groups. The 

statistics in Table 4-7 are shown as modified boxplots in Figure 4. In this figure, xq25 is shown as a 

blue inverted triangle and xq75 as a blue upright triangle, and the box connecting these quantities is 

not drawn. The maximum dose is shown as a red bull’s eye, and the minimum dose as a red diamond 

when no left censored data were present. Each dose in a quarter that is larger (on a log scale) than 

log(xq75) + 1.5 × [log(xq75) – log(xq25)] is shown as a black plus sign (+). All data points in a 

quarter that are smaller (on a log scale) than log(xq25) + 1.5 × [log(xq75) – log(xq25)] are also shown 

as plus signs, although these may be incomplete when there are a large number of zero doses. In each 

of the four pairs of box plots in Figure 1, the left-hand plot is for Group 1 during the quarter and the 

right-hand for Group 2. In addition, a horizontal line is shown at 300 mrem, corresponding to 10 

percent of the quarterly Radiation Protection Guidelines dose in 1961, and it is clear that fewer than a 

dozen workers from either group had doses above this level in any quarter. Because Group 1 

contained approximately 1200 workers each quarter and Group 2 more than 4000, at most one-half of 

one percent of the doses for either group in any quarter were above 10 percent of the Radiation 

Protection Guidelines. 

Table 4-7: Descriptive Statistics for 1961 Y-12 Quarterly Gamma Doses for Two Groups of Workers 

Partitioned by Monitoring Status in 1960 

Quarter 

Q1 Q2 Q3 Q4 

Group 1a 2b 1 2 1 2 1 2 

25th Percentile 5.4 3.7 43.8 30.4 18.9 9.9 46.2 34.4 

Median 12.8 10.2 63.4 38.5 35.8 16.3 67.2 45.1 

75th Percentile 27.8 16.8 98.2 51.3 67.1 25.5 103.7 56.4 

max dose 1810 1,621 710 1276 1791 2173 483 1,413 

K-M Meanc 38.4 15.8 84.5 47.3 52.4 25.4 82.6 55.4 

Cumulative Dosed 39,350 25,943 103,323 202,773 63,123 108,285 99,962 241,033 

Cumulative Dose, 

Adjustede 47,078 64,385 103,428 203,437 63,142 108,941 99,946 241,267 

% Below MDLf 53.1 85.9 0.5 0.7 0.1 1.2 0.0 0.1 

Ng 1,226 4,075 1,224 4,301 1,205 4,289 1,210 4,355 

Notes: 

a Y-12 workers selected to be monitored in 1960 b

 Y-12 workers not monitored in 1960 

c

 Kaplan-Meier mean; product-limit estimate of the mean using censored data methods with an upper limit of 30 

mrem for doses recorded as 0 

d

 Dose accumulative by adding all recorded quarterly doses for the group e

 Cumulative dose adjusted upward by using left-censored methods with an upper limit of 30 mrem for doses 

recorded as 0

 f Percent of records recorded as 0 to indicate below MDL g Number of quarterly doses for the group 

Figure 4. Modified Box Plots for Y-12 Quarterly Gamma Doses in 1961 for Two Groups of Workers 

Partitioned by Monitoring Status in 1960 

38 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Altogether 65 workers, including 35 in Group 1 and 30 in Group 2, had at least one quarterly dose 

greater than 300 mrem. Group 1 workers were known to have higher exposure potential since they had 

been selected for monitoring in 1960. Group 2 workers were not expected to have potential for higher 

exposure, although these 30 individuals received a quarterly dose above 300 mrem in 1961 when all 

workers began being monitored. Information was gathered to investigate why these 30 workers had 

not been selected for monitoring in 1960. Collected data included hire dates, dates of change for job 

titles and departments, monitoring data for earlier years, and all quarterly gamma doses for 1961 

through 1965. 

4.4.1 Analysis of “Why Not Monitored?” Group for Gamma Doses 

The 30 Group 2 workers who were not monitored at Y-12 in 1960 and had a quarterly doses greater 

than 300 mrem in 1961 will be referred to as the “why not monitored?” group. Results of this 

investigation are presented in Table 2. For those individuals whose annual gamma dose was above 

1200 mrem, which was 10 percent of yearly Radiation Protection Guidelines, each quarterly dose for 

1961 and the highest quarterly dose for 1962 are also given in the table. 

The total number of workers in Group 2 was approximately 300 greater during the remainder of 1961 

than in Q1, indicating that new employees were likely hired during Q1. Hire dates revealed that four 

of the “why not monitored?” group were not employed at Y-12 in 1960, and two addition members 

worked only part of 1960. Among the remaining 24 individuals, eighteen had only one quarter with 

39 of 81-Appendix 1 
 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

dose above 300 mrem. Dates of change for job titles and departments uncovered five more members 

of the “why not monitored?” group who changed departments in the second half of 1960 or early in 

1961, which may have resulted in increasing their exposure potential. Seven group members had been 

monitored during the late 1950s and were found to have low gamma doses at that time, with the 

exception of one quarterly dose of 337 mrem. 

For the remaining 12 members of the “why not monitored?” group, the explanation of why they were 

not selected for monitoring in 1960 is less obvious. However, in 1961 eight of these 12 workers had 

only one quarterly dose above 300 mrem and an annual dose below 10 percent of the yearly Radiation 

Protection Guidelines. The highest quarterly dose in 1962 for six of these eight workers was below 

300 mrem; one chemical operator and one development mechanic had a quarterly dose in 1962 above 

this limit. Among the four workers with annual doses in 1961 above 1200 mrem, one was a welder 

with three quarterly doses each below 80 mrem and a Q3 dose of 1413. The final three individuals 

were all development mechanics who appeared to have quarterly doses that were consistently above 

300 mrem. 

The dose assignment methodology for unmonitored quarters before 1961 includes a scaling factor 

based on an individual’s doses after 1961 (ORAUT-PROC-0042). For the scaling factor to be applied, 

the worker must have been monitored for at least five quarters during the period from 1961-1965 and 

must have routine duties and work location essentially the same during the 1950s and early 1960s. 

This scaling factor would be implemented to adjust doses derived for each unmonitored quarter before 

1961 for all of the approximately 4000 Y-12 workers (including members of the “why not 

monitored?” group) who met the two criteria. In particular, the development mechanics, chemical 

operator, and welder, for whom there is no clear explanation of why they were not monitored before 

1961, would also receive claimant favorable doses due to the scaling factor adjustment. It is notable 

that out of over 5000 Y-12 workers only six (about one-tenth of one percent) may have been 

overlooked when selecting workers to be monitor in 1960. 

Table 4-8A: Job and 1961 Gamma Dose Information for Y-12 Workers Not Selected for Monitoring in 1960 and 

Having a Quarterly Dose above 300 mrem in 1961 

Annual 

1961 

Dose 

Highest 

1961 

Dose 

Job Title Department 

Comments Monitoring 

Quarters 

1961-1965a 

Not a Y-12 employee during all of 1960 

First Hired 04-10-61 

1961 Doses 

 Quarter 2=41 

1518 1413 Machinist 2703 Quarter 3=64 16 

 Quarter 4=1413 

All 4 Doses for 1962-Below 80 

Group 2 Max Quarter 4 dose 

1198 1170 Coop. 

Student 2619 First Hired 01-09-61 11 

1163 871 Assembler 2722 First Hired 01-31-61 20 

614 362 Machinist 2003 First Hired 10-03-60 20 

516 460 2077 Hired 01-16-61 17 

40 of 81-Appendix 1 
 

 

 

Comments 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-8A: Job and 1961 Gamma Dose Information for Y-12 Workers Not Selected for Monitoring in 1960 and 

Having a Quarterly Dose above 300 mrem in 1961 

Annual 

1961 

Dose 

Highest 

1961 

Dose 

Job Title Department 

Comments Monitoring 

Quarters 

1961-1965a 

Not a Y-12 employee during all of 1960 

Electrician 

501 322 Lab 

Trainee 2259 

Hired 03-01-60 

High Dose in Quarter 4 

13 

Notes:
 a

 Number of quarters of monitoring data from 1961-1965. Any worker with at least five monitored quarters in
 

1961-1965 (with similar job duties and location before and after 1961) has a scaling factor applied to the assigned
 

dose for each unmonitored quarter before 1960. 

Table 4-8B: Job and 1961 Gamma Dose Information for Y-12 Workers Not Selected for Monitoring in 1960 and 

Having a Quarterly Dose above 300 mrem in 1961 

Previously monitored in late 1950s with same job tasks 

Annual 

1961 

Dose 

Highest 

1961 

Dose 

Job Title Department Monitoring 

Quarters 

1961-1965a 

Monitored in 1956 and 1957-Low Doses 

1961 Doses 

 Q1=8

2493 2173 Craft 

Foreman 2703 Q2=220  Q3=2173 19 

 Q4=92 

Highest 1962 Dose-98 

Group 2 max Q3 Dose 

Monitored in 1958 and 1959-Low Doses 

1961 Doses 

Mechanic- Q1=305 

1745 883 Devel. 2018 Q2=883 19 

 Q3=230 

 Q4=327 

Highest 1962 Dose-429 

Monitored in 1958 and 1959-Low Doses 

1961 Doses 

Mechanic- Q1=212 

1298 552 Devel. 2018 Q2=129 5 

 Q3=552 

 Q4=405 

Highest 1962 dose 215 

792 323 Receiving 

Clerk 2701 

Monitored in 1958 and 1959-Three Low 

Doses and One Dose of 337 

Changed from dept. 2128 on 10-03-60 

20 

756 337 Machine 

Operator 2776 Monitored in 1957-Dose 0 19 

368 318 Metal 

Worker 2003 Monitored in 1958 and 1959-Low Doses 20 

362 316 Cleaner 2659 Monitored in 1958 and 1959-Low Doses 20 

Notes: 

41 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 a

 Number of quarters of monitoring data from 1961-1965. Any worker with at least five monitored quarters in 

1961-1965 (with similar job duties and location before and after 1961) has a scaling factor applied to the assigned 

dose for each unmonitored quarter before 1960. 

Table 4-8C: Job and 1961 Gamma Dose Information for Y-12 Workers Not Selected for Monitoring in 1960 and 

Having a Quarterly Dose above 300 mrem in 1961 

Change in department or job tasks between 1960 and 1961 

Annual 

1961 

Dose 

Highest 

1961 

Dose 

Job Title Department Comments Monitoring 

Quarters 

1961-1965a 

1686 1621 Engineer 2057 

Changed from dept. 2058 on 08-01-60 

1961 Doses 

 Q1=1621 

 Q2=23 

 Q3=16 

 Q4=26 

Highest 1962 Dose-6 

Group 2 max Q1 Dose 

5 

1202 401 

MechanicDevel. 2018 

Switched from machinist on 09-19-60 

1961 Doses 

 Q1=337 

 Q2=309 

 Q3=157 

 Q4=401 

Highest 1962 Dose-557 

20 

775 395 Chemical 

Operator 2638 Changed from dept. 2638 on 06-27-60 20 

516 356 Production 

Operator 2722 Changed from dept. 2687 on 01-16-61 20 

Notes:
 a

 Number of quarters of monitoring data from 1961-1965. Any worker with at least five monitored quarters in
 

1961-1965 (with similar job duties and location before and after 1961) has a scaling factor applied to the assigned
 

dose for each unmonitored quarter before 1960. 

Table 4-8D: Job and 1961 Gamma Dose Information for Y-12 Workers Not Selected for Monitoring in 1960 and 

Having a Quarterly Dose above 300 mrem in 1961 

Unclear why not monitored in 1960 

Annual 

1961 

Dose 

Highest 

1961 

Dose 

Job Title Department Comments Monitoring 

Quarters 

1961-1965a 

2443 1127 

MechanicDevel. 2018 

1961 Doses 

 Q1=590 

 Q2=360 

 Q3=366 

 Q4=1127 

Highest 1962 Dose-1,018 

19 

2210 1276 

MechanicDevel. 2018 

1961 Doses 

 Q1=378 

 Q2=1276 

 Q3=316 

 Q4=240 

Highest 1962 Dose-277 

Group 2 max Q2 Dose 

20 

42 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 4-8D: Job and 1961 Gamma Dose Information for Y-12 Workers Not Selected for Monitoring in 1960 and 

Having a Quarterly Dose above 300 mrem in 1961 

Unclear why not monitored in 1960 

Annual 

1961 

Dose 

Highest 

1961 

Dose 

Job Title Department Comments Monitoring 

Quarters 

1961-1965a 

1582 617 

MechanicDevel. 2018 

1961 Doses - Q1=362 

 Q2=617 

 Q3=323 

 Q4=280 

Highest 1962 Dose-956 

19 

1557 1413 Welder 2158 

1961 Doses 

 Q1=14 

 Q2=77 

 Q3=1413 

 Q4=53 

Highest 1962 Dose-178 

19 

1106 624 MechanicDevel. 2820 Highest 1962 Dose-200 20 

905 624 MechanicDevel. 2018 Highest 1962 Dose-71 20 

798 381 MechanicDevel. 2018 Highest 1962 Dose-296 20 

751 309 File 

Clerk 2617 Highest 1962 Dose-59 20 

683 310 Process 

Operator 2619 Highest 1962 Dose-264 19 

649 333 Chemical 

Operator 2617 Highest 1962 Dose-569 19 

504 327 MechanicDevel. 2018 Highest 1962 Dose-861 19 

370 318 MechanicDevel. 2158 Highest 1962 Dose-65 18 

357 300 Record 

Clerk 2018 Highest 1962 Dose-19 20 

Note: 

a

 Number of quarters of monitoring data from 1961-1965. Any worker with at least five monitored quarters in
 

1961-1965 (with similar job duties and location before and after 1961) has a scaling factor applied to the assigned
 

dose for each unmonitored quarter before 1960. 

4.5 Comparison of Maximum Monitoring Data Results 

Available monitoring data (CER databases) for members of the proposed class show that plumbers, 

pipefitters, and steamfitters were monitored at a frequency similar to that of the Y-12 work force as a 

whole. During the 1948 through 1957 period approximately 10% of the nearly 300 proposed class 

members were monitored at some time externally and approximately 30 % were monitored internally 

(urinalysis). Based on analyses presented in the preceding subsections, it is assumed that the proposed 

class members chosen for monitoring were those performing the highest exposure potential activities. 

The following table presents a comparison between the maximum monitoring results of the proposed 

class members and of non-class members. This comparison indicates that as a class, even the most 

highly exposed plumbers, pipefitters, and steamfitters were not as highly exposed as other types of Y43 of 81-Appendix 1 
 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

12 workers. The comparison further confirms that sufficient data are available to calculate 

conservative, maximum potential doses for the proposed class members. 

Table 4-9: Comparison of Maximum Internal and External Annual Monitoring Resultsa Between 

Members of the Proposed Classb

 and Non-Class Membersc 

Year Data Set Gamma Beta Neutron Urinalysis 

50 

Non Class 

P. Classb 

0 

-

0 

-

0 

-

795 

4 

51 

Non Class 

P. Classb 

0 

0 

0 

0 

0 

0 

11,100 

18 

52 

Non Class 

P. Classb 

934 

600 

3,133 

0 

18 

0 

38,865 

48 

53 

Non Class 

P. Classb 

1,215 

0 

4,605 

300 

85 

0 

9,975 

8 

54 

Non Class 

P. Classb 

3,595 

0 

6,961 

287 

592 

0 

28,291 

321 

55 

Non Class 

P. Classb 

1,220 

751 

8,522 

751 

654 

0 

36,967 

470 

56 

Non Class 

P. Classb 

1,282 

0 

5,234 

90 

81 

0 

7,145 

771 

57 

Non Class 

P. Classb 

974 

83 

5,829 

826 

60 

0 

25,414 

199 

Notes: 

a

 Results for external measurements are mrem. Results for internal measurements are disintegration per minute 

(dpm). b

 Proposed Class of Plumbers, Pipefitters, and Steamfitters. c

 All Y-12 employees that are not members of the proposed class definition 

- = No data available 

5.0 Additional Analysis by Department 

The following sections provide additional analysis by department. 

5.1 Gamma Dose Analysis 

The modified boxplots below for 1956 through 1965 are for departments with highest potential for 

external exposure. The corresponding table for each boxplot contains the summary statistics used to 

construct the boxplot. Comparing doses before and after 1961, it is apparent that there was dose levels 

after 1961 were not elevated above levels for earlier years when only selected individuals were 

monitored. In fact, when all workers were monitored, the dose distribution for several of these higher 

exposure potential departments dropped rather than rose. Only department 2619 showed some rising 

in dose distributions after 1961. However, levels were very similar to the mid-1950s, and nearly all 

quarterly doses were below 10% of the Radiation Protection Guidelines. 

44 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028
 

Figure 5. Modified Boxplot for Gamma Doses in Department 2233 

45 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

( year, 

quarter) 

Kmm1 

Table 5-1: Department 2233 Summary Statistics for Gamma Doses 

Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

56 Q1 NA NA NA NA NA NA NA NA NA 100 NA 6 

56 Q3 NA NA NA NA NA NA NA NA NA 93.8 NA 32 

56 Q4 48.9 7.8 17.7 32.4 50 282 0.771 1,195 1,614 42.4 1 33 

57 Q1 100.5 7.9 62.2 83.1 127.5 217 0.531 3,889 3,920 2.6 0 39 

57 Q2 37.8 7.4 15.3 17.5 26.4 260 0.401 1,242 1,663 52.3 6 44 

57 Q3 45.1 7.1 8.7 25.9 48.8 221 1.281 1,879 2,210 42.9 0 49 

57 Q4 26.3 2.7 17.1 23.4 25.6 98 0.297 383 1,210 80.4 3 46 

58 Q1 42.7 6 23.2 27.4 35 232 0.305 1,334 1,964 54.3 7 46 

58 Q2 58.4 9.4 17 26.7 58.8 291 0.921 2,626 2,745 12.8 0 47 

58 Q3 113.7 15.8 29 78 177 449 1.341 4,197 4,321 18.4 0 38 

58 Q4 152.1 23.8 18.3 102 205 600 1.791 5,913 6,236 31.7 0 41 

59 Q1 175.4 25 58.8 102.5 259.3 562 1.1 6,824 6,841 2.6 0 39 

59 Q2 52.2 11.3 11.9 23.7 71.5 461 1.332 3,519 3,550 57.4 0 68 

59 Q3 69.7 10.9 19.3 40.5 83 319 1.081 2,973 3,206 28.3 0 46 

59 Q4 75.6 11.8 30.5 45.8 93 432 0.826 2,825 2,948 12.8 0 39 

60 Q1 28.4 4.8 11 12 25.9 190 0.638 1,179 1,477 36.5 4 52 

60 Q2 36.4 7.5 5.1 10.6 33.4 365 1.395 1,948 2,220 34.4 0 61 

60 Q3 59.9 10.9 7.4 34 57 303 1.515 2,865 2,875 2.1 0 48 

60 Q4 75.2 10.8 16.1 37 94 485 1.306 4,908 5,114 16.2 0 68 

61 Q1 44.9 4.8 7.5 18 57.2 472 1.506 6,830 7,633 38.8 0 170 

61 Q2 87.6 3.9 46.1 75 108.7 307 0.636 18,084 18,133 1.4 0 207 

61 Q3 59.2 6.2 23.2 45 69.6 1054 0.816 10,840 10,834 0 1 183 

61 Q4 97.7 3.7 52.1 84.6 131.1 261 0.684 20,605 20,615 0 0 211 

62 Q1 28.8 8.7 4.8 16.8 34 76 1.451 218 230 12.5 0 8 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

Date 

( year, 

quarter) 

Kmm1 

Table 5-2: Department 2618 Summary Statistics for Gamma Doses 

Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

57 Q4 32 4.3 16.6 21.2 37.5 70 0.603 325 448 42.9 0 14 

58 Q1 38.2 5 16.4 27.9 43.8 125 0.726 897 1,108 34.5 0 29 

58 Q2 192.8 24.6 87 174 275 450 0.853 4,598 4,627 4.2 0 24 

58 Q3 152.7 25.1 69 113 200 495 0.789 3,908 3,970 11.5 0 26 

46 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 5-2: Department 2618 Summary Statistics for Gamma Doses 

Date 

( year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

58 Q4 82.6 10.9 51.8 71 89.3 262 0.404 1,734 1,735 0 1 21 

59 Q2 41.5 16.1 11.2 22.5 37 807 0.883 2,237 2,241 64.8 2 54 

59 Q3 155.9 12.2 51.5 149.5 201.7 530 1.012 14,622 14,810 13.7 0 95 

59 Q4 119.4 10.2 21.2 87 175.8 587 1.568 15,787 16,358 25.5 0 137 

60 Q1 85.7 5.9 23.3 52.5 118.8 448 1.208 19,143 19,625 11.4 0 229 

60 Q2 107.7 5.9 33.8 86 147.2 493 1.091 26,068 26,279 6.1 0 244 

60 Q3 115.2 7.1 56 95.5 165.5 346 0.803 14,025 14,054 1.6 0 122 

60 Q4 189.5 9.8 129 190.5 259 390 0.517 15,347 15,350 0 0 81 

61 Q1 38.6 4.3 8.9 21.8 57 291 1.379 3,291 3,783 38.8 0 98 

61 Q2 106.9 4.6 73.7 105.5 129.5 280 0.418 11,011 11,011 0 0 103 

61 Q3 68.5 4.1 34.5 68 96.8 159 0.764 6,129 6,165 2.2 0 90 

61 Q4 108.6 5.6 68.9 108.5 133.2 483 0.489 10,750 10,751 0 1 99 

62 Q1 50.6 3.6 25 47.3 69.5 121 0.758 3,944 3,947 0 0 78 

62 Q2 144.1 11.9 90 131 156 734 0.408 10,949 10,952 0 3 76 

62 Q3 99.6 14.6 48.5 79.5 97.4 1025 0.517 7,270 7,271 0 2 73 

62 Q4 71 3.7 45.8 72.9 88.6 175 0.49 5,252 5,254 0 0 74 

63 Q1 39.6 6 6.2 32 41.4 536 1.405 3,485 3,643 14.1 0 92 

63 Q2 34.7 4 13.3 17.5 43.6 215 0.88 2,781 3,297 33.7 0 95 

63 Q3 37.8 4.9 2.6 25.7 54.9 273 2.269 3,189 3,440 27.5 0 91 

63 Q4 22 1.6 12.2 16.7 24.8 83 0.524 1,424 2,090 41.1 1 95 

64 Q1 42.3 1.6 16.9 34.4 43.5 156 0.699 4,063 5,922 44.3 0 140 

64 Q2 40.4 2.5 26.1 28 33.6 191 0.188 3,646 5,656 52.1 27 140 

64 Q3 88.5 3.9 56.3 74.3 110.5 235 0.5 12,364 12,390 0.7 0 140 

64 Q4 54.5 3.4 25 44.3 70.9 233 0.773 7,261 7,466 8.8 0 137 

65 Q1 20 2 8.3 14.3 23.1 152 0.761 1,444 2,120 45.3 1 106 

65 Q2 26 2.6 10.2 19.5 29 130 0.777 1,637 1,768 11.8 0 68 

65 Q3 33.2 3.3 17.2 26.8 38.3 171 0.59 2,192 2,191 0 1 66 

65 Q4 37.1 3 20.6 29.3 45.5 108 0.586 1,890 1,892 0 0 51 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

47 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028
 

Figure 6. Modified Boxplot for Gamma Doses in Department 2618 

48 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028
 

Figure 7. Modified Boxplot for Gamma Doses in Department 2619 

49 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 5-3: Department 2619 Summary Statistics for Gamma Doses 

Date 

( by year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

56 Q1 115 22.1 25.3 78.5 142 513 1.278 3,105 3,105 14.8 0 27 

56 Q2 77.5 12.7 38 48 96 218 0.687 1,535 1,550 10 0 20 

56 Q3 378.8 35.8 261.5 378 502.3 649 0.484 7,197 7,197 0 0 19 

56 Q4 168.9 39.3 26.3 100 208.8 701 1.537 3,367 3,547 28.6 0 21 

57 Q1 160.6 18.8 110 154 192.5 332 0.415 2,830 2,891 11.1 0 18 

57 Q2 209.1 26.6 116 190 264 479 0.61 3,346 3,346 0 0 16 

57 Q3 157.4 25.2 23.6 150 216 513 1.642 3,253 3,463 31.8 0 22 

57 Q4 61.2 9.9 22.9 32 93 178 1.039 1,132 1,224 20 0 20 

58 Q1 83.2 15.5 38 56 115.5 188 0.824 1,165 1,165 0 0 14 

58 Q2 195.8 24.9 123.5 186 239.5 399 0.491 2,741 2,741 0 0 14 

58 Q3 182.2 19.4 116 180 225 316 0.491 2,186 2,186 0 0 12 

58 Q4 246.4 18.2 186.5 237.5 274.6 425 0.287 3,696 3,696 0 0 15 

59 Q1 222.3 26.1 188.2 199.5 218.2 585 0.11 3,335 3,334 0 1 15 

59 Q2 79.5 13.3 30.8 57 95.5 211 0.84 1,231 1,352 23.5 0 17 

59 Q3 147.5 19.4 97 136 176 326 0.442 2,360 2,360 0 0 16 

59 Q4 127.8 15.3 89.2 121.5 155.5 294 0.412 2,211 2,300 16.7 0 18 

60 Q1 93.4 11.4 43 76 143 196 0.891 2,226 2,242 4.2 0 24 

60 Q2 169.8 18.2 115.4 159 183.3 517 0.343 3,905 3,905 0 1 23 

60 Q3 125.7 8.6 92 125 151.8 222 0.371 2,891 2,891 0 0 23 

60 Q4 86.7 14 26.6 76 114.5 169 1.082 896 954 18.2 0 11 

61 Q1 18.6 2.6 4 10 18.9 228 1.153 1,826 3,013 64.8 3 162 

61 Q2 61.2 3.2 34.1 45.2 69.8 228 0.531 9,664 9,670 0 1 158 

61 Q3 46 5 13.4 23 51 612 0.99 7,267 7,268 0 1 158 

61 Q4 72 4.8 41 52.4 76.6 472 0.464 11,155 11,160 0 6 155 

62 Q1 29.3 2.8 4.2 13.8 39 278 1.654 4,343 4,336 0 0 148 

62 Q2 77.5 4.7 44.1 60.4 92.2 388 0.547 11,546 11,548 0 3 149 

62 Q3 76 5 43.8 63 86.4 422 0.504 11,092 11,096 0 5 146 

62 Q4 65.1 5 23.9 46.2 79.8 440 0.894 9,426 9,440 0.7 0 145 

63 Q1 74.1 8.4 5.4 37 111 448 2.239 8,090 8,447 29.8 0 114 

63 Q2 92.9 9.8 17.6 52 132 576 1.494 10,123 10,405 15.2 0 112 

63 Q3 113.6 10.6 23.1 75.5 169.9 469 1.478 12,115 12,382 17.4 0 109 

63 Q4 68.4 7 18.4 26.4 87 344 1.152 6,927 7,387 22.2 0 108 

64 Q1 159.4 16.4 48 137.5 262.8 403 1.26 7,509 7,811 20.4 0 49 

64 Q2 141.3 15.7 32 119.5 201.2 390 1.363 6,171 6,500 23.9 0 46 

64 Q3 187.2 19.2 77 166 280.8 525 0.959 8,800 8,798 0 0 47 

64 Q4 195.9 23.8 28 190 289 604 1.73 7,705 7,836 17.5 0 40 

65 Q1 142.5 28.6 22.3 74.5 173 511 1.519 3,983 4,132 24.1 0 29 

65 Q2 56.4 13.7 12 31 52 267 1.087 1,269 1,354 25 0 24 

65 Q3 128.3 19 50.5 104 150 344 0.807 2,823 2,823 0 0 22 

65 Q4 181.2 26.3 79 146 243.5 435 0.834 3,987 3,986 0 0 22 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

50 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

Figure 8. Modified Boxplot for Gamma Doses in Department 2701 

51 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 5-4: Department 2701 Summary Statistics for Gamma Doses 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

56 Q3 94.3 11.2 30.4 61.2 123.5 342 1.04 4,100 4,432 23.4 0 47 

56 Q4 280 17.8 185 288 365 481 0.504 14,439 14,560 7.7 0 52 

57 Q1 99.1 9.5 32.2 86 130.3 300 1.035 4,994 5,351 22.2 0 54 

57 Q2 82.2 10.4 10.3 57 128.8 395 1.871 4,576 4,685 15.8 0 57 

57 Q3 157.2 14.5 52 138 242 447 1.14 9,280 9,432 15 0 60 

57 Q4 30.2 3.6 16.7 18.2 32.2 167 0.487 1,359 1,721 33.3 2 57 

58 Q1 106.3 7.3 62.5 105 141.5 251 0.606 6,518 6,591 4.8 0 62 

58 Q2 218.5 11 166 209 247 516 0.295 13,108 13,110 0 1 60 

58 Q3 163.7 15.3 110 151.8 196 895 0.428 9,955 9,986 4.9 1 61 

58 Q4 147.8 16.4 35.5 139 193.5 1,170 1.257 10,985 11,528 23.1 0 78 

59 Q1 216.7 8.7 168.4 213.5 258.2 615 0.317 25,700 25,787 2.5 3 119 

59 Q2 175.4 11.7 102.5 180 223 915 0.576 16,252 16,488 8.5 1 94 

59 Q3 122 8.6 67 125.6 160.2 594 0.646 11,468 11,590 6.3 1 95 

59 Q4 148.4 13.2 103 143 170.5 1,290 0.374 15,289 15,434 10.6 2 104 

60 Q1 171.2 15.9 105 153 191 1,227 0.444 14,359 14,381 1.2 3 84 

60 Q2 96.8 8.1 49.2 77 120.5 435 0.663 8,284 8,325 3.5 0 86 

60 Q3 163.4 7.8 95.9 161.5 205.8 737 0.566 24,023 24,020 0 1 147 

60 Q4 119.9 8.1 48.5 106 159.5 685 0.882 16,886 17,026 4.9 0 142 

61 Q1 22.8 2.3 8 12.9 25.1 255 0.852 2,985 4,150 50 2 182 

61 Q2 70.2 2.7 44.3 62.7 85.5 309 0.487 13,909 13,900 0 1 198 

61 Q3 44.2 2.4 21.7 33.9 55.3 280 0.694 8,781 8,796 0.5 1 199 

61 Q4 78.6 3.1 47.5 69 92.4 323 0.493 15,569 15,563 0 2 198 

62 Q1 34.6 3.8 5.2 17.4 45 166 1.6 3,596 3,598 0 0 104 

62 Q2 91.6 5.4 54.8 75 105 326 0.483 8,980 8,977 0 2 98 

62 Q3 94.3 11.8 46.1 71.2 99.1 1,114 0.567 9,615 9,619 0 3 102 

62 Q4 89.5 9.7 43.4 70.8 106 873 0.662 8,859 8,860 0 1 99 

63 Q1 31.4 3.9 3.3 25.9 37 266 1.782 3,112 3,485 27 0 111 

63 Q2 32.1 3.6 10.6 16.2 41 208 1.002 2,882 3,595 42.9 0 112 

63 Q3 38.9 6.3 2.7 25.2 33.1 564 1.847 4,008 4,746 41.8 0 122 

63 Q4 19.4 2 8.4 13 23.2 174 0.75 1,407 2,464 59.1 1 127 

64 Q1 42.6 3.3 12.9 25.8 41.5 339 0.866 2,642 4,473 58.1 1 105 

64 Q2 36.6 4.1 21.1 23.4 27.9 255 0.207 1,961 3,733 70.6 13 102 

64 Q3 65.9 10.8 30.5 49 71.8 1,077 0.635 6,578 6,590 1 1 100 

64 Q4 36.3 5.4 7.4 21.6 40 440 1.255 3,078 3,630 40 0 100 

65 Q1 35.9 5.3 11.5 21.1 39.6 343 0.919 2,828 3,410 37.9 2 95 

65 Q2 42.3 6.6 9.5 23.5 51.5 473 1.254 3,457 3,638 17.4 0 86 

65 Q3 51.9 12 15.2 29.1 47 907 0.834 4,150 4,152 0 2 80 

65 Q4 31.9 1.7 20.9 27.7 34.6 88 0.375 2,517 2,520 0 4 79 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose 

52 of 81-Appendix 1 
 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

Figure 9. Modified Boxplot for Gamma Doses in Department 2702 

53 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 5-5: Department 2702 Summary Statistics for Gamma Doses 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

56 Q1 NA NA NA NA NA NA NA NA NA 0 NA 3 

56 Q2 115.7 15.6 15.5 64 168.8 388 1.772 5,815 6,132 28.3 0 53 

56 Q3 231.2 25.8 86.2 183.5 322.8 977 0.978 11,669 11,791 7.8 0 51 

56 Q4 403 30 252.3 345 552.3 955 0.581 18,880 18,941 4.3 0 47 

57 Q1 161.4 15.8 63 137.5 219 487 0.924 7,366 7,424 4.3 0 46 

57 Q3 399.2 43.6 193 266 651.5 974 0.902 15,109 15,170 5.3 0 38 

57 Q4 172 27.2 52.5 131 218.5 695 1.057 6,516 6,536 2.6 0 38 

58 Q1 170.3 21.3 63.5 121.5 214.3 599 0.901 7,280 7,323 4.7 0 43 

58 Q2 421.3 33.1 319.3 407.5 524.3 971 0.368 16,402 16,431 2.6 0 39 

58 Q3 613.9 36.4 459.8 539 723 1,196 0.336 21,485 21,486 0 0 35 

58 Q4 314.5 26.2 217.5 275 344.8 754 0.341 11,008 11,008 0 1 35 

59 Q1 423.6 34.9 318.7 370 520.2 1,015 0.363 12,283 12,284 0 0 29 

59 Q2 361 84.8 154 277 363 2,540 0.636 10,109 10,108 0 1 28 

59 Q3 91.6 14.3 40 66.2 77.8 500 0.493 2,932 2,931 0 1 32 

59 Q4 300.9 16.6 219 320 383.8 505 0.416 12,637 12,638 0 0 42 

60 Q1 129.9 10.3 82 126 160 324 0.496 4,647 4,676 2.8 0 36 

60 Q2 288.5 16.3 224.2 292 349.3 489 0.328 12,405 12,406 0 0 43 

60 Q3 302.1 11.3 260.4 294.5 348.2 499 0.216 12,992 12,990 0 0 43 

60 Q4 313.3 12.7 270.2 322 372.5 427 0.238 10,964 10,966 0 0 35 

61 Q1 69.5 26.6 12.2 22.7 41.4 1,052 0.903 3,123 3,266 21.3 2 47 

61 Q2 108.1 6.3 82.2 97.7 117.5 257 0.264 4,973 4,973 0 2 46 

61 Q3 93.9 5.5 69.8 88.2 106.1 205 0.311 4,415 4,413 0 2 47 

61 Q4 119.3 7.6 88.5 107 127.5 393 0.271 5,490 5,488 0 2 46 

62 Q1 60.6 7.7 21 51 78.5 211 0.977 2,364 2,363 0 0 39 

62 Q2 133.3 16.2 79 114 135 574 0.397 4,800 4,799 0 3 36 

62 Q3 115.6 15.5 69.9 94.4 118.1 493 0.389 4,279 4,277 0 2 37 

62 Q4 121.7 7.1 80.6 110.5 135.4 213 0.385 4,747 4,746 0 0 39 

63 Q1 65.8 8.8 28 58.3 79.5 266 0.774 2,605 2,632 7.5 0 40 

63 Q2 55.5 8.2 19 47 58.7 265 0.836 2,111 2,220 15 0 40 

63 Q3 56.6 7.1 26 36 66 237 0.691 2,131 2,264 15 0 40 

63 Q4 32.2 3.8 13.1 22.4 47.8 87 0.958 1,024 1,191 29.7 0 37 

64 Q1 60.3 5.2 23.1 39.2 82.5 260 0.943 3,739 4,462 32.4 0 74 

64 Q2 59.2 5.3 25.8 50 71.5 319 0.756 4,050 4,381 17.6 0 74 

64 Q3 109.2 7.2 65.5 96.5 137 298 0.547 8,036 8,081 2.7 0 74 

64 Q4 73.9 8.6 25.4 47 85.5 341 0.9 5,162 5,321 12.5 0 72 

65 Q1 77.7 10.6 19 50 95.5 403 1.195 4,975 5,128 13.6 0 66 

65 Q2 74.2 11.8 24.5 43 60.5 526 0.67 4,493 4,600 8.1 5 62 

65 Q3 84.8 10.3 40.5 62 81.3 349 0.516 5,260 5,258 0 8 62 

65 Q4 114.4 13.3 43 63 155 448 0.951 6,862 6,864 0 0 60 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

54 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

Figure 10. Modified Boxplot for Gamma Doses in Department 2703 

55 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

(year, 

quarter) 

Kmm1 

Table 5-6: Department 2703 Summary Statistics for Gamma Doses 

Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

56 Q1 29 0.6 7.2 14.3 21.5 110 0.814 350 5,046 96.6 0 174 

56 Q4 125.9 6.3 37.2 102 188 507 1.2 30,796 31,223 11.7 0 248 

57 Q1 136.2 5.2 85.3 131 169.9 504 0.511 25,865 25,878 2.6 1 190 

57 Q2 60.5 4.8 17.1 30.5 78.8 418 1.134 11,447 12,402 26.8 0 205 

57 Q3 40.9 2.7 12.6 28.3 55.5 209 1.101 7,255 7,935 21.6 0 194 

57 Q4 32.6 2.3 17 18.7 26.3 180 0.324 4,219 6,487 56.3 25 199 

58 Q1 52.9 3.3 17.9 35.1 64 247 0.945 10,296 11,215 22.2 0 212 

58 Q2 114.9 7.2 31.4 75.3 177.8 665 1.286 23,076 23,554 10.7 0 205 

58 Q3 120.2 5 69 111.7 155.4 433 0.602 27,913 28,247 7.2 0 235 

58 Q4 89.7 4.3 31.6 69 121 422 0.995 24,552 25,834 18.1 0 288 

59 Q1 151.2 5.1 93.2 143.5 195.9 610 0.55 46,938 47,326 5.8 1 313 

59 Q2 43.2 3.2 15.6 35 62.3 311 1.029 12,059 12,182 44 0 282 

59 Q3 43.5 2.7 15.8 26 46.3 410 0.799 12,221 14,094 31.5 5 324 

59 Q4 73.1 3.1 32.2 54 102.2 450 0.856 24,107 25,585 18.6 0 350 

60 Q1 44.3 3.2 11.8 23.8 51.7 581 1.094 13,585 15,062 26.2 1 340 

60 Q2 60.9 3.5 19.5 43.8 76.5 571 1.014 19,984 20,402 8.1 0 335 

60 Q3 57.3 2.7 22.8 45.5 74.2 256 0.874 16,052 16,216 3.2 0 283 

60 Q4 97.6 3.7 61 85.5 121.6 348 0.511 24,938 25,083 2.7 1 257 

61 Q1 11 1.8 2.5 4.9 12.2 156 1.182 671 1,276 64.7 1 116 

61 Q2 58.8 2.2 43.3 54.7 69.5 220 0.35 8,026 8,056 1.5 2 137 

61 Q3 55.2 11.8 25.3 39.1 52.8 2,173 0.545 10,102 10,102 0 2 183 

61 Q4 81.6 7.5 57 69.2 82.2 1,413 0.272 15,427 15,422 0 8 189 

62 Q1 23.4 1.9 5.4 16.4 32 123 1.313 3,071 3,089 0.8 0 132 

62 Q2 79.8 2.8 58.4 69.8 90 214 0.321 10,213 10,214 0 2 128 

62 Q3 71.5 3.6 45 66.1 90.2 336 0.516 8,914 8,938 0.8 1 125 

62 Q4 64.6 2.7 46.4 52.8 76 268 0.365 8,207 8,204 0 1 127 

63 Q1 24.3 2.3 4.5 25.1 34.5 150 1.509 2,385 2,916 40 0 120 

63 Q2 30.5 2 14.5 18.5 45.7 147 0.85 3,328 3,934 28.7 0 129 

63 Q3 38.1 3.3 8.9 29.9 57.8 287 1.389 4,540 4,839 20.5 0 127 

63 Q4 24.3 1.7 12 19 25.1 118 0.546 2,391 3,038 29.6 3 125 

64 Q1 34.7 1.1 9.6 19.2 28.7 98 0.814 1,296 3,991 78.3 0 115 

64 Q2 37.7 6.7 23.7 25.3 27.4 756 0.107 2,010 4,298 76.3 10 114 

64 Q3 61.1 3.9 37.8 48.4 67.2 292 0.427 6,950 6,965 0.9 3 114 

64 Q4 18.1 1.7 6.4 14.3 23.7 119 0.968 1,635 2,082 31.3 0 115 

65 Q1 21.5 2.8 7.9 15.9 23.9 233 0.823 1,651 2,386 47.7 3 111 

65 Q2 22.6 5.4 4.6 12.4 22.4 220 1.173 891 972 16.3 0 43 

65 Q3 24.9 1.9 15.2 22.5 30.5 56 0.514 945 946 0 0 38 

65 Q4 26.9 1.5 18.6 22.7 30 61 0.354 1,184 1,184 0 0 44 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

56 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

Figure 11. Modified Boxplot for Gamma Doses in Department 2793 

57 of 81-Appendix 1 
 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 5-7: Department 2793 Summary Statistics for Gamma Doses 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

57 Q1 NA NA NA NA NA NA NA NA NA 71.4 NA 7 

57 Q2 23.6 3.8 12.5 17.2 26.3 47 0.55 192 260 36.4 0 11 

57 Q3 48.4 9.3 8 16.1 41 157 1.209 923 1,258 61.5 0 26 

57 Q4 42.7 7.2 8.1 17.2 49.3 165 1.334 1,022 1,281 50 0 30 

58 Q1 36.3 4 20.5 25.5 38.5 107 0.469 1,025 1,343 37.8 1 37 

58 Q2 135 12.7 70.5 114.5 177.3 521 0.683 6,829 6,885 5.9 0 51 

58 Q3 138.4 11.4 69.3 118 197.6 522 0.777 8,946 8,996 4.6 0 65 

58 Q4 86.2 8.2 28.1 64.5 124.5 292 1.104 5,483 5,775 17.9 0 67 

59 Q1 110.6 8.1 56 96 150 366 0.73 7,876 7,963 5.6 0 72 

59 Q2 78.3 9.6 21.3 61 115 405 1.252 5,315 5,324 27.9 0 68 

59 Q3 61 6.5 17.3 45 90 303 1.224 3,770 3,904 14.1 0 64 

59 Q4 157.3 14.8 85 157 184.5 796 0.574 9,364 9,438 5 1 60 

60 Q1 75.1 9.4 15.6 58 108.5 394 1.44 3,984 4,055 9.3 0 54 

60 Q2 92.6 9.1 36.5 80 129 357 0.936 4,970 5,000 3.7 0 54 

60 Q3 113.1 9.2 60 101.5 148 358 0.669 6,763 6,786 1.7 0 60 

60 Q4 108.5 8.7 54 101 140 325 0.706 6,050 6,076 1.8 0 56 

61 Q1 18.3 2.5 6.6 12.6 26.6 58 1.032 513 750 41.5 0 41 

61 Q2 73.8 4.1 54.9 70 88.8 126 0.356 3,080 3,100 2.4 0 42 

61 Q3 48 3.2 29 42 61.5 101 0.557 2,206 2,208 0 0 46 

61 Q4 84.4 5.6 57.3 77.5 101 240 0.42 3,797 3,798 0 1 45 

62 Q1 33.6 3.7 12.7 29.3 43.5 110 0.91 1,277 1,277 0 0 38 

62 Q2 85.1 5.8 56 79 98 196 0.415 3,063 3,064 0 0 36 

62 Q3 69.4 8.7 45.2 66.1 72.2 347 0.347 2,569 2,568 0 1 37 

62 Q4 80.7 8 46.5 75 98 226 0.553 2,905 2,905 0 0 36 

63 Q1 32.4 4.1 5.5 32 39.7 81 1.462 1,079 1,102 8.8 0 34 

63 Q2 41.5 4.3 15.9 42 58.1 94 0.96 1,329 1,452 20 0 35 

63 Q3 47 8.3 10.1 31 67 215 1.401 1,515 1,598 17.6 0 34 

63 Q4 24.6 4 7 19.4 26.4 117 0.983 597 886 47.2 0 36 

64 Q1 39 4.2 11.7 23.4 37.2 124 0.856 496 975 64 0 25 

64 Q2 47.5 6.6 15.8 30.5 50 155 0.853 936 1,140 29.2 0 24 

64 Q3 98.3 11.1 62 80 121 256 0.496 2,262 2,261 0 0 23 

64 Q4 27 4.7 9.2 14.4 34.8 81 0.986 536 621 26.1 0 23 

65 Q1 31.3 5.4 9 22.5 33 106 0.963 834 1,002 34.4 0 32 

65 Q2 37.5 6.8 15.7 22.4 57.5 196 0.962 1,083 1,162 16.1 0 31 

65 Q3 37 4.9 11.9 27.5 60.5 79 1.207 1,072 1,073 0 0 29 

65 Q4 49.2 5.6 24 37 58 130 0.654 1,477 1,476 0 0 30 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 

58 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 12 Total number of quarterly doses 

The following two modified boxplots for 1956-1965 are for the departments with low potential for 

external exposure that had a large number of working quarters before and after 1961. Because of the 

low exposure potential, most of the quarters before 1961 were not monitored in these departments. 

The corresponding tables contain the summary statistics used to obtain the boxplots. It is evident that 

gamma doses for nearly all of these workers were so low that they did not even reach the level of 10% 

of the Radiation Protection Guidelines. In fact, approximately 75% of the doses were below 1% of 

the Radiation Protection Guidelines each quarter. 

Figure 12. Modified Boxplot for Gamma Doses in Department 2014 

59 of 81-Appendix 1 
 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

(year, 

quarter) 

Kmm1 

Table 5-8: Department 2014 Summary Statistics for Gamma Doses 

Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

59 Q4 NA NA NA NA NA NA NA NA NA 0 NA 3 

60 Q1 NA NA NA NA NA NA NA NA NA 33.3 NA 3 

61 Q1 12.9 2.1 4.6 12.1 16.3 56 0.946 255 1,883 91.1 0 146 

61 Q2 42.4 1.4 29.9 39.3 50.1 124 0.383 6,019 6,021 0 2 142 

61 Q3 19.2 1.2 9.9 14 23.5 98 0.643 2,686 2,688 0 1 140 

61 Q4 47.5 1.4 35.8 45.1 52.8 142 0.288 6,314 6,318 0 2 133 

62 Q1 13.4 1.1 2.6 5.1 13.8 147 1.248 3,131 3,122 0 0 233 

62 Q2 40.7 3 28.9 34.7 43.4 675 0.302 9,032 9,035 0 5 222 

62 Q3 38.9 2.2 21.4 27 43.2 355 0.518 8,640 8,636 0 6 222 

62 Q4 24.9 2.1 2.9 20.5 26 346 1.616 5,582 5,602 0.4 0 225 

63 Q1 11 1.4 2.4 4.6 6.5 155 0.741 1,132 2,398 71.1 14 218 

63 Q2 15.3 1 9.1 13.2 17.4 76 0.482 710 3,458 85.4 5 226 

63 Q3 14.3 3 0.7 2.4 17.3 502 2.383 2,030 3,418 75.3 0 239 

63 Q4 16.2 2 8.1 12.2 17.6 65 0.571 510 3,823 93.6 5 236 

64 Q1 30.2 0.1 7.7 15.4 23.1 42 0.814 220 6,704 97.3 0 222 

64 Q2 21.7 0.5 5.4 10.7 16.1 113 0.814 298 4,514 96.6 1 208 

64 Q3 28.6 2.6 9.2 17.8 27.2 225 0.807 5,516 6,063 17.5 10 212 

64 Q4 17 4.4 3.2 8.5 14.7 853 1.117 1,875 3,519 84.5 2 207 

65 Q1 15.8 1.1 5.4 10.9 18.8 139 0.926 2,722 3,602 32 1 228 

65 Q2 16.3 2.2 3.9 8.6 16.1 292 1.058 2,635 3,586 42.7 4 220 

65 Q3 20.8 3 5.5 11.7 17.9 582 0.881 4,492 4,493 0 4 216 

65 Q4 32.6 0.9 24.2 31.2 34.6 134 0.266 6,982 7,009 0.5 4 215 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

Date 

(year, 

quarter) 

Kmm1 

Table 5-9: Department 2018 Summary Statistics for Gamma Doses 

Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

60 Q4 NA NA NA NA NA NA NA NA NA 100 NA 3 

61 Q1 20 3.3 2.8 4 12.1 590 1.085 4,655 6,980 85.4 14 349 

61 Q2 67.3 5.9 31 38.1 53.7 1,276 0.407 23,606 23,622 0.3 35 351 

61 Q3 29 2.7 10.6 16.7 25.2 552 0.641 9,987 10,034 0.9 15 346 

60 of 81-Appendix 1 
 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Table 5-9: Department 2018 Summary Statistics for Gamma Doses 

Date 

(year, 

quarter) 

Kmm1 Kmse2 xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

61 Q4 60.8 3.9 37.3 45.9 57 1,127 0.313 20,966 20,976 0 23 345 

62 Q1 28.1 4.4 3.6 7.1 18.3 896 1.213 10,083 10,088 0.3 8 359 

62 Q2 56.7 4.4 32.8 42.4 52.1 956 0.344 19,008 18,994 0 21 335 

62 Q3 57.8 4 23.6 41.2 61.7 702 0.711 19,938 19,941 0 6 345 

62 Q4 38.5 3.8 18.6 23.8 43.8 1,018 0.635 13,275 13,321 0.9 8 346 

63 Q1 30.8 5.1 2.3 4.9 26.3 1,082 1.81 8,807 10,657 56.4 1 346 

63 Q2 27.3 3.2 10.7 14.6 19.5 779 0.445 6,390 9,473 56.8 34 347 

63 Q3 26.7 4 0.7 5.7 26.1 949 2.643 6,407 9,185 70.1 0 344 

63 Q4 21.3 1.7 10 15.8 22.9 280 0.616 2,387 7,348 85.5 9 345 

64 Q1 39.3 3.7 8.1 16.2 24.2 757 0.814 3,041 10,454 92.9 7 266 

64 Q2 33.6 2.8 24.4 25.7 27.6 598 0.093 2,413 8,602 90.2 19 256 

64 Q3 30.4 3.2 8.9 16.9 33 633 0.974 7,373 8,026 18.9 2 264 

64 Q4 19.4 3.1 3.6 8.9 16 411 1.098 2,735 4,908 82.2 5 253 

65 Q1 28.9 2.3 6.6 16.2 40.3 367 1.337 6,288 6,965 24.5 0 241 

65 Q2 29.2 3.7 4.9 11.8 23.3 421 1.159 5,676 6,512 31.8 4 223 

65 Q3 27.7 3.7 7.4 12 21 597 0.775 6,212 6,205 0 12 224 

65 Q4 38.9 2.8 24.1 32 37.5 449 0.327 8,553 8,558 0 12 220 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

61 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Figure 13. Modified Boxplot for Gamma Doses in Department 2018 

5.2 Beta Dose Analysis 

The modified boxplots below for 1956-65 are for departments with highest potential for external 

exposure. The corresponding table for each boxplot contains the summary statistics used to construct 

the boxplot. In no instance did the dose distribution rise when complete monitoring began in 1961. 

For most of the departments with high exposure potential, monitoring was fairly complete even before 

1961. 

62 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028
 

Figure 14. Modified Boxplot for Beta Doses in Department 2233, 1956-1965 

63 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

(year, 

quarter) 

Kmm1 Kmse2 

Table 5-10: Department 2233 Summary Statistics 

xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

56 Q1 425.2 58.2 269 444 487.5 594 0.441 2,551 2,551 0 0 6 

56 Q3 170.5 18.5 75 135.7 227 435 0.821 5,455 5,456 0 0 32 

56 Q4 457.7 66.9 211.2 271.5 559.5 1,814 0.722 15,104 15,104 0 0 33 

57 Q1 545.5 54.4 314.2 489.5 644.5 2,139 0.532 21,276 21,274 0 1 39 

57 Q2 541.9 84.3 190.7 227 665 2,329 0.926 23,845 23,844 0 0 44 

57 Q3 449.5 57.5 194.2 240.3 580 1,733 0.811 22,026 22,026 0 0 49 

57 Q4 316.8 37 187.5 202.7 308.5 1,333 0.369 14,572 14,573 0 4 46 

58 Q1 281.4 27.9 193.6 211 256 1,042 0.207 12,946 12,944 0 7 46 

58 Q2 112.1 13.8 50.2 65 143.8 398 0.779 5,269 5,269 0 0 47 

58 Q3 367.1 68 32.2 149 573.5 1,533 2.134 13,886 13,950 10.5 0 38 

58 Q4 314.6 58.6 40.6 140.5 412.5 1,435 1.718 12,849 12,899 7.3 0 41 

59 Q1 408.1 61.4 31.5 291.8 646 1,325 2.239 15,897 15,916 2.6 0 39 

59 Q2 272.4 41.9 27.9 107 305 1,242 1.774 18,511 18,523 1.5 0 68 

59 Q3 256.4 46.6 55 102 326.5 1,365 1.32 11,796 11,794 0 0 46 

59 Q4 206.7 41.1 58.5 114.8 253.3 1,180 1.086 8,061 8,061 0 0 39 

60 Q1 103 17.5 19 43.5 140 546 1.482 5,259 5,356 11.5 0 52 

60 Q2 87.6 13 29.9 56.5 83 466 0.757 5,345 5,344 0 4 61 

60 Q3 260.7 80.7 26.6 44 205 3,051 1.513 12,482 12,514 4.2 0 48 

60 Q4 168.7 34.7 24 46 142 1,368 1.318 11,471 11,472 0 0 68 

61 Q1 532.8 44.1 46 356 827 2,963 2.142 90,242 90,576 11.2 0 170 

61 Q2 497.7 45.5 40.8 206.5 738.8 3,450 2.148 102,783 103,024 8.7 0 207 

61 Q3 409.9 42.7 46.8 216.5 490.8 ,069 1.743 74,919 75,012 2.7 0 183 

61 Q4 442.9 44.7 47.5 189.2 505.3 3,816 1.753 93,318 93,452 4.3 0 211 

62 Q1 355.6 146.8 4 15 841 930 3.965 2,845 2,845 0 0 8 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

Date 

(year, 

quarter) 

Kmm1 Kmse2 

Table 5-11: Department 2618 Summary Statistics 

xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

57 Q4 662.8 119.7 309.5 524 762 1,644 0.668 9,279 9,279 0 0 14 

58 Q1 601.8 77.4 182.8 536 903.5 1,711 1.185 17,453 17,452 0 0 29 

58 Q2 1151 206.4 243 595 1548 3,674 1.373 27,625 27624 0 0 24 

58 Q3 911.3 170.5 188 504 1,341.5 3,084 1.457 23,695 23,694 0 0 26 

58 Q4 212.1 66 15.8 54.5 178.3 987 1.799 4,239 4,454 38.1 0 21 

64 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

(year, 

quarter) 

Kmm1 Kmse2 

Table 5-11: Department 2618 Summary Statistics 

xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

59 Q2 235 54 11.9 83.5 328.5 2,532 2.459 12,645 12,690 5.6 0 54 

59 Q3 516.5 67.9 26 211 826.5 3,440 2.565 48,522 49,068 24.2 0 95 

59 Q4 555.8 59.1 46.1 290.5 843.7 3,890 2.155 75,836 76,145 14.6 0 137 

60 Q1 449.6 42 28.6 166 594.5 3,300 2.25 102,504 102,958 10 0 229 

60 Q2 663.8 46.5 92 429 985 4,751 1.757 161,727 161,967 5.7 0 244 

60 Q3 770.7 71.8 78 479 1,148.5 3,457 1.994 93,958 94,025 3.3 0 122 

60 Q4 615.6 69.8 45.8 430 1,047.2 2,900 2.321 49,818 49,864 3.7 0 81 

61 Q1 727.4 55.8 275 564 1176 2,124 1.077 71,209 71,285 9.2 0 98 

61 Q2 970.2 69.1 442.5 929.5 1,296.2 3,071 0.797 99,891 99,931 4.9 0 103 

61 Q3 775.5 65.5 202 665 1,101.5 2,539 1.257 69,787 69,795 1.1 0 90 

61 Q4 740.5 56.9 269.5 620.5 1,040.2 2,508 1.001 73,274 73,310 4 0 99 

62 Q1 645.3 61.8 170.5 526 1,039.5 2,218 1.34 50,272 50,333 3.8 0 78 

62 Q2 1340 108.3 422 1248 2,087 4,266 1.185 101,796 101,840 2.6 0 76 

62 Q3 795.1 65 293 745.5 1,118.2 2,196 0.993 57,968 58,042 4.1 0 73 

62 Q4 707.5 71.3 214.2 553 982 2,728 1.129 52,349 52,355 4.1 0 74 

63 Q1 594.4 84.3 92 372 651 4,415 1.45 54,481 54,685 8.7 0 92 

63 Q2 610.9 66.7 85.8 386 899 2,519 1.742 57,991 58,036 9.5 0 95 

63 Q3 802.2 100 151.5 597 931.7 5,825 1.347 72960 73,000 3.3 0 91 

63 Q4 610.5 68.1 138 449 686.5 3,047 1.189 57,935 57,998 4.2 0 95 

64 Q1 421.7 38.3 70 331 570 2,366 1.555 58,888 59,038 7.9 0 140 

64 Q2 552.7 40.1 241 442 706 2,789 0.797 77,373 77,378 0 0 140 

64 Q3 837.5 56.2 410 653 1,005 3,034 0.665 117,227 117,250 0.7 0 140 

64 Q4 959 66.7 381.7 722 1,325 3,810 0.922 130,994 131,383 9.5 0 137 

65 Q1 362.2 36.6 67.5 222 5,81.5 2,035 1.596 38,201 38,393 12.3 0 106 

65 Q2 577.1 76.9 128 374 633 2,924 1.185 39,203 39,243 2.9 0 68 

65 Q3 345.9 37.8 98 242 540 1,312 1.265 22,799 22,829 3 0 66 

65 Q4 424.1 54.6 107.5 332.5 633.5 1,572 1.315 21,587 21,629 7.8 0 51 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

65 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028
 

Figure 15. Modified Boxplot for Beta Doses in Department 2618, 1956-1965 

66 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028
 

Figure 16. Modified Boxplot for Beta Doses in Department 2619, 1956-1965 

67 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

(year, 

quarter) 

Kmm1 Kmse2 

Table 5-12: Department 2619 Summary Statistics 

xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

56 Q1 1,066 155 437.2 915 1,244 3,250 0.775 28,783 28,782 0 0 27 

56 Q2 1,221.1 193.3 505 879 1,460 3,727 0.787 24,422 24,422 0 0 20 

56 Q3 1,408.2 199.9 802.5 1,203 1,629.8 3,933 0.525 26,756 26,756 0 0 19 

56 Q4 996 193.7 138.8 883.5 1231 3,803 1.618 20,916 20,916 0 0 21 

57 Q1 1,354.2 189.9 804 1127 1,983.5 2,805 0.669 24,376 24,376 0 0 18 

57 Q2 1,109.6 142.9 553 1,091 1,471 2,140 0.725 17,753 17,754 0 0 16 

57 Q3 653.7 118.7 96.5 482 1,057 1,923 1.774 14,382 14,381 0 0 22 

57 Q4 682.3 105.2 232 513 1031 1,665 1.106 13,646 13,646 0 0 20 

58 Q1 711 147.6 246 627 742.5 2,216 0.819 9,954 9,954 0 0 14 

58 Q2 410.6 76.7 106.5 351 541.5 1,062 1.205 5,719 5,748 7.1 0 14 

58 Q3 692.9 123.4 284 640 777 1,800 0.746 8,315 8,315 0 0 12 

58 Q4 706.9 73.2 369.8 727.5 933.9 1,102 0.687 10,603 10,604 0 0 15 

59 Q1 638.4 50.4 461.5 652.5 742 1,020 0.352 9,576 9,576 0 0 15 

59 Q2 481.1 104.4 89 371.5 597.5 1,580 1.412 8,059 8,179 23.5 0 17 

59 Q3 476 69.9 233 406 611 1,162 0.715 7,616 7,616 0 0 16 

59 Q4 369.8 78.3 133 230 578 1,330 1.089 6,566 6,656 16.7 0 18 

60 Q1 217.7 75.1 18.4 47 270 1,690 1.991 5,061 5,225 33.3 0 24 

60 Q2 748.9 121.3 271.3 516.5 1,088.8 1,968 1.03 17,203 17,225 4.3 0 23 

60 Q3 383.7 70.6 113.5 243.5 518.2 1,249 1.126 8,796 8,825 4.3 0 23 

60 Q4 379.8 116.7 132 213 532.9 1,455 1.034 4,118 4,178 18.2 0 11 

61 Q1 114.3 12.2 20.6 43.3 123.3 717 1.325 17,716 18,517 26.5 0 162 

61 Q2 95.8 12 12 27.5 118.3 1,085 1.698 14,737 15,136 18.4 0 158 

61 Q3 127 21.9 12.2 28.8 117.5 2,534 1.681 19,842 20,066 9.5 0 158 

61 Q4 75 15.3 9.4 18.3 72.2 1,657 1.512 11,051 11,625 29 1 155 

62 Q1 81 15 12.6 26.7 73 1,699 1.303 11,539 11,988 19.6 1 148 

62 Q2 151.5 31.7 22.3 49 102.5 2,965 1.132 22,169 22,574 15.4 4 149 

62 Q3 116.1 18.8 19.5 36 88.3 1,707 1.118 16,356 16,951 21.9 4 146 

62 Q4 94.2 18.1 4.9 24.8 40.8 1,552 1.564 12,425 13,659 56.6 3 145 

63 Q1 60.7 9.3 12.2 23.2 70.5 697 1.299 6,131 6,920 46.5 0 114 

63 Q2 77.2 17.2 1.8 19.8 69 1,261 2.702 8,085 8,646 44.6 0 112 

63 Q3 110.1 27.8 10.6 23.8 73.2 2,156 1.431 11,203 12,001 46.8 2 109 

63 Q4 76.2 12.4 15.2 28.1 79 1,069 1.223 7,594 8,230 35.2 1 108 

64 Q1 28 5.5 7.5 14.4 23 197 0.827 811 1,372 71.4 2 49 

64 Q2 54.3 17.4 6.5 16.3 36.5 671 1.274 2,130 2,498 58.7 1 46 

64 Q3 19 2.9 8.5 13.6 16.8 92 0.504 214 893 85.1 1 47 

64 Q4 19.3 4.2 8.9 12.9 14.4 168 0.357 319 772 85 3 40 

65 Q1 44 15 6.5 13.1 22.9 405 0.932 851 1,276 75.9 3 29 

65 Q2 20.7 7.5 3.3 7.3 19.9 174 1.334 365 497 54.2 0 24 

65 Q3 46.6 21.6 3.2 9.6 24 449 1.485 886 1,025 54.5 0 22 

65 Q4 NA NA NA NA NA NA NA NA NA 90.9 NA 22 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

68 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

Figure 17. Modified Boxplot for Beta Doses in Department 2701, 1956-1965 

69 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

(year, 

quarter) 

Kmm1 Kmse2 

Table 5-13: Department 2701 Summary Statistics 

xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

56 Q3 1,228.4 115.7 569 1117.5 1547.5 3,833 0.742 57,734 57,735 0 0 47 

56 Q4 800.3 95.1 265 550 1,060 3,290 1.028 41,613 41,616 0 0 52 

57 Q1 1,430.2 145.3 604.5 1194 1,769.5 5,255 0.796 77,233 77,231 0 0 54 

57 Q2 950 97 366.8 682 1,357.8 3,268 0.97 54,148 54,150 0 0 57 

57 Q3 780.2 94.9 241 513 1,042 3,465 1.085 46,810 46,812 0 0 60 

57 Q4 764.1 92.1 243.2 538.5 939.8 3,028 1.002 43,556 43,554 0 0 57 

58 Q1 668.3 75.6 241.5 495 757 3,017 0.847 41,433 41,435 0 0 62 

58 Q2 503 47.6 255 393 602 1,634 0.637 30,149 30,180 1.7 0 60 

58 Q3 484.9 51.3 195.2 347 691.8 1,633 0.938 29,561 29,579 1.6 0 61 

58 Q4 237.2 29.1 24 109 344 947 1.974 18,284 18,502 16.7 0 78 

59 Q1 211.7 22.2 34.1 116 285.2 1,322 1.575 24,783 25,192 16.8 0 119 

59 Q2 210.1 24.8 14.1 140 295.5 1,153 2.255 19,648 19,749 7.4 0 94 

59 Q3 173.7 24.1 13 87.7 241.2 1,472 2.168 16,097 16,502 27.4 0 95 

59 Q4 248.3 42.5 14.8 95 295 2,880 2.22 25,512 25,823 17.3 0 104 

60 Q1 646.7 41.5 339 595 935 1,750 0.752 54,295 54,323 1.2 0 84 

60 Q2 193.7 23.3 26.8 156 244 1,007 1.636 16,629 16,658 2.3 0 86 

60 Q3 632.6 68.2 66.5 272 807.8 3,544 1.851 92,898 92,992 4.1 0 147 

60 Q4 301.4 43.6 42.2 90 308.5 3,435 1.475 42,692 42,799 4.9 0 142 

61 Q1 254.8 29 41.7 170 358.5 4,475 1.595 46,024 46,374 13.2 0 182 

61 Q2 182 13.1 37.7 118.5 261.5 799 1.436 35,795 36,036 12.1 0 198 

61 Q3 184.8 14.2 45.3 115.5 259.8 1,441 1.294 36,683 36,775 3 0 199 

61 Q4 184.5 20.4 24.6 85 230.5 2,403 1.657 36,124 36,531 13.1 0 198 

62 Q1 276.9 27.5 68.7 169 407 1,438 1.319 28,702 28,798 4.8 0 104 

62 Q2 392 35.7 143 291 549 1,582 0.997 38,365 38,416 3.1 0 98 

62 Q3 402.6 37.1 84.5 276 615 2,051 1.471 41,022 41,065 2 0 102 

62 Q4 281.6 31.6 28.9 154 431 1,195 2.004 27,644 27,878 11.1 0 99 

63 Q1 150.8 17.7 33.8 88 159.2 1,097 1.15 16,310 16,739 18.9 0 111 

63 Q2 180.1 18.8 23.3 109 257 926 1.78 19,889 20,171 21.4 0 112 

63 Q3 256.2 22.9 28.4 172.3 383.5 1,143 1.93 30,909 31,256 13.1 0 122 

63 Q4 183.7 14.6 38.2 135.5 300.2 699 1.527 23,215 23,330 6.3 0 127 

64 Q1 203.2 24.2 21.6 120 275.7 1,451 1.888 21,131 21,336 12.4 0 105 

64 Q2 181.8 20.4 55.8 133 190.5 1,161 0.91 18,487 18,544 2.9 0 102 

64 Q3 166.8 15.5 58 102 224 652 1.002 16,637 16,680 2 0 100 

64 Q4 225.6 32.9 16.3 80 318 1,947 2.202 21,177 22,560 46 0 100 

65 Q1 230.3 39.2 22.4 145.5 263.5 3,424 1.826 21,564 21,878 17.9 0 95 

65 Q2 357.6 43.9 71.5 248 442.5 2,314 1.351 30,709 30,754 4.7 0 86 

65 Q3 179.7 18.2 46 119 267 642 1.304 14,276 14,376 7.5 0 80 

65 Q4 97.7 10.1 13.2 71.8 144.1 375 1.771 7,546 7,718 19 0 79 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

70 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

Figure 18. Modified Boxplot for Beta Doses in Department 2702, 1956-1965 

71 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

year, 

quarter) 

Kmm1 Kmse2 

Table 5-14: Department 2702 Summary Statistics 

xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

56 Q1 NA NA NA NA NA NA NA NA NA 0 NA 3 

56 Q2 1,744.9 126.7 1,005.7 1,625.5 2,478.7 3,828 0.669 92,479 92,480 0 0 53 

56 Q3 1,643.2 128.6 934.2 1,455 1,864.5 4,419 0.512 83,802 83,803 0 0 51 

56 Q4 1,234.7 181.1 338.5 707.5 1,631 5,234 1.166 58,029 58,031 0 0 47 

57 Q1 1,911.1 187.7 905.5 1,728 2,574 5,829 0.774 87,912 87,911 0 0 46 

57 Q3 1,290.9 142.4 522 1,098 1,725 3,621 0.886 49,053 49,054 0 0 38 

57 Q4 906.2 89.3 432 725 1,236 2,606 0.779 34,434 34,436 0 0 38 

58 Q1 565.2 57.5 293.5 422 745.3 1,550 0.691 24,302 24,304 0 0 43 

58 Q2 833.8 76 468 823 1107 1,789 0.638 32,518 32,518 0 0 39 

58 Q3 779.6 73 434 705.5 1,110.5 2,032 0.696 27,287 27,286 0 0 35 

58 Q4 591.3 70.2 272.5 565 690.5 1,671 0.689 20,696 20,696 0 0 35 

59 Q1 904.4 117.8 275.7 800.8 1,368.5 2,245 1.188 26,199 26,228 3.4 0 29 

59 Q2 871.7 105.8 305 763 1,370 1,875 1.114 24,407 24,408 0 0 28 

59 Q3 2,070.8 284.5 715 1,530 3,400 5,956 1.156 66,266 66,266 0 0 32 

59 Q4 1,799.9 268.7 578 1,343 2,316.5 10,407 1.029 75,596 75,596 0 0 42 

60 Q1 434.1 48.6 210 340 547 1,265 0.71 15,627 15,628 0 0 36 

60 Q2 1,285 132 496.8 1,100.5 2,019.3 3,186 1.04 55,227 55,255 2.3 0 43 

60 Q3 903 99.9 276 699 1,424.3 2,255 1.216 38,831 38,829 0 0 43 

60 Q4 1,226.8 170.7 265.8 999 2,030.3 3,628 1.507 42,937 42,938 0 0 35 

61 Q1 496.3 74.1 88 305.5 805.8 2,221 1.642 23,306 23,326 2.1 0 47 

61 Q2 696.3 126.2 165.5 364 735 4,379 1.105 31,998 32,030 2.2 0 46 

61 Q3 697.2 84.7 224.5 551.5 949 2,547 1.069 32,768 32,768 0 0 47 

61 Q4 577.5 75.7 180.2 412 813 2,431 1.117 26,563 26,565 0 0 46 

62 Q1 559.1 82.8 189.8 430.5 718 2,177 0.986 21,805 21,805 0 0 39 

62 Q2 761 113.9 150 587 1,086 2,450 1.467 27,397 27,396 0 0 36 

62 Q3 667.8 108.5 155 503.5 817 2,986 1.232 24,710 24,709 0 0 37 

62 Q4 781.3 142.6 140.1 358 1,063.5 3,700 1.502 30,469 30,471 0 0 39 

63 Q1 461.1 73.4 123 304.5 603 2,328 1.178 18,380 18,444 10 0 40 

63 Q2 399.9 78.7 51 184 525 1,966 1.728 15,944 15,996 12.5 0 40 

63 Q3 560.2 135.6 108 297 566 4,539 1.228 22,388 22,408 2.5 0 40 

63 Q4 343.6 59.9 120.5 226 416 1,998 0.918 12,655 12,713 5.4 0 37 

64 Q1 417.9 54.4 72.2 279 645 2,352 1.623 30,834 30,925 8.1 0 74 

64 Q2 429.2 71.7 93 170 458 3,368 1.182 31,703 31,761 4.1 0 74 

64 Q3 362.9 61 62.7 119 477 2,792 1.504 26,840 26,855 1.4 0 74 

64 Q4 304.1 48 99 156 343.5 2,283 0.922 21,565 21,895 15.3 1 72 

65 Q1 212.4 40.8 48.5 111 192.5 1,758 1.022 13,888 14,018 10.6 2 66 

65 Q2 262.7 43.8 62 120 268.5 1,761 1.087 16,263 16,287 3.2 0 62 

65 Q3 236.1 47 40.5 80.5 243.5 1,739 1.33 14,604 14,638 4.8 0 62 

65 Q4 214.6 40.8 44 93 219 1,579 1.19 12,774 12,876 11.7 0 60 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

72 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

Figure 19. Modified Boxplot for Beta Doses in Department 2703, 1956-1965 

73 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

year, 

quarter) 

Kmm1 Kmse2 

Table 5-15: Department 2703 Summary Statistics 

xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

56 Q1 890 35.7 587 798 1,043 2,619 0.426 154,852 154,860 0 2 174 

56 Q4 533.7 33.3 235 346 582 2,998 0.672 132,352 132,358 0 7 248 

57 Q1 948.1 56 459 729 1,038.5 4,439 0.605 180,144 180,139 0 2 190 

57 Q2 751.8 41.7 324.5 614.5 932.5 3,393 0.782 154,099 154,119 0.5 0 205 

57 Q3 557 33.3 243.7 406 728.5 3,096 0.812 108,048 108,058 0.5 0 194 

57 Q4 531.4 29.7 244.5 390 628.8 2,599 0.7 105,743 105,749 0 1 199 

58 Q1 638.9 32.8 270 507 889 2,898 0.883 135,451 135,447 0 0 212 

58 Q2 289 16.8 96.3 237.8 411.8 1,520 1.077 59,129 59,245 2.4 0 205 

58 Q3 440.1 21.5 224.8 402.5 572.5 2,620 0.693 103,289 103,424 3 1 235 

58 Q4 441.6 20.7 189 397 618 2,755 0.878 126,909 127,181 5.9 0 288 

59 Q1 372.4 15.8 148.5 326 519 1,235 0.928 116,224 116,561 4.5 0 313 

59 Q2 368.6 16.9 171.3 321 495.5 1,989 0.788 103,709 103,945 5.7 0 282 

59 Q3 367.5 17.6 159 321 505 2,430 0.857 118,699 119,070 6.5 0 324 

59 Q4 384.4 18.3 149 293 560.5 2,209 0.982 134,216 134,540 5.4 0 350 

60 Q1 266.6 21.5 60 151 332 5,109 1.268 90,379 90,644 3.8 1 340 

60 Q2 337 25 95.9 202 388 5,910 1.036 112,788 112,895 1.8 1 335 

60 Q3 398.9 24.4 135.8 274 493 2,848 0.956 112,806 112,889 1.4 0 283 

60 Q4 453.8 28.6 158.6 284.5 606.7 3,360 0.994 116,605 116,627 0.4 0 257 

61 Q1 286.4 26 111 200 383 2,148 0.918 33,093 33,222 6 0 116 

61 Q2 250.9 18.4 87.5 166 348.7 999 1.025 34,279 34,373 5.1 0 137 

61 Q3 380.8 24.1 122.5 285 545.8 1,835 1.108 69,651 69,686 1.6 0 183 

61 Q4 315.6 18.6 136.5 257.5 413.3 1,630 0.821 59,543 59,648 2.6 0 189 

62 Q1 351.1 27.9 119 271 463 1,860 1.007 46,321 46,345 1.5 0 132 

62 Q2 530.9 44.9 181 413 595 2,985 0.882 67,957 67,955 0 0 128 

62 Q3 499.6 38.8 182.8 405.5 680.3 2,986 0.974 62,409 62,450 1.6 0 125 

62 Q4 407.5 35.1 141.2 295.5 573 2,787 1.038 51,633 517,52 3.9 0 127 

63 Q1 276.6 24.3 70 214 414 1,433 1.318 32,794 33,192 15 0 120 

63 Q2 304.9 25.3 76.8 244.5 478.5 1,809 1.357 39,168 39,332 14 0 129 

63 Q3 447.1 32.6 125.7 350 652.5 1,523 1.221 56,632 56,782 6.3 0 127 

63 Q4 301.2 16.9 179.3 274 414.3 1,093 0.621 37,616 37,650 1.6 0 125 

64 Q1 214.8 20 63.2 123.9 302.7 916 1.161 24,576 24,702 7 0 115 

64 Q2 226.3 13.6 125 189.8 311.1 733 0.676 25,583 25,798 7 0 114 

64 Q3 285.2 17.6 130.5 236 424 990 0.874 32,509 32,513 0 0 114 

64 Q4 198.9 17.5 18.4 164 324 1,071 2.128 21,462 22,874 40.9 0 115 

65 Q1 148.4 15.4 19.2 113 220.5 898 1.808 16,279 16,472 14.4 0 111 

65 Q2 221.9 38.9 39 109.5 257.3 909 1.398 9,523 9,542 2.3 0 43 

65 Q3 207.8 32.8 51 145.5 251 901 1.181 7,888 7,896 2.6 0 38 

65 Q4 250 55.3 32 134 285 2,151 1.621 10,921 11,000 13.6 0 44 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose 

74 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

Figure 20. Modified Boxplot for Beta Doses in Department 2793, 1956-1965 

75 of 81-Appendix 1 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

(year, 

quarter) 

Kmm1 Kmse2 

Table 5-16: Department 2793 Summary Statistics 

xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

57 Q1 766.7 72 560 719 882 1,021 0.337 5,367 5,367 0 0 7 

57 Q2 348 62.8 186.5 259 460 731 0.669 3,828 3,828 0 0 11 

57 Q3 288.4 52.1 134.8 195 279 1,209 0.54 7,498 7,498 0 1 26 

57 Q4 567.9 88.9 193.5 344 746 2,033 1 17,036 17,037 0 0 30 

58 Q1 293.4 33.4 185.7 253.5 330.5 1,039 0.427 10,855 10,856 0 2 37 

58 Q2 285 28.8 137.8 229.5 369 982 0.73 14,537 14,535 2 0 51 

58 Q3 427.4 28.6 281.3 391 528 1,200 0.467 27,765 27,781 1.5 0 65 

58 Q4 334.8 33.1 101.8 273.5 472 1,142 1.137 22,355 22,432 6 0 67 

59 Q1 241.1 25.2 100 180 318 1,002 0.858 17,273 17,359 5.6 0 72 

59 Q2 373.5 41.9 115 283 504 1,655 1.095 25,398 25,398 1.5 0 68 

59 Q3 334.8 31.4 146 285 478 1,210 0.879 21,405 21,427 1.6 0 64 

59 Q4 387.7 43.3 105 293 517 1,350 1.182 23,234 23,262 1.7 0 60 

60 Q1 245.8 39.6 42.5 146 308 1,315 1.468 13,230 13,273 3.7 0 54 

60 Q2 356.2 57.8 57 167 452.5 2,045 1.536 19,155 19,235 9.3 0 54 

60 Q3 341.5 59.6 94 208 318 2,720 0.903 20,466 20,490 1.7 1 60 

60 Q4 370 37.9 133 289 533 1,137 1.029 20,722 20,720 0 0 56 

61 Q1 238.7 41 93.8 150.3 264.5 1,375 0.769 9,746 9,787 4.9 1 41 

61 Q2 196 28.9 61 138 222.5 869 0.959 8,163 8,232 7.1 0 42 

61 Q3 214.7 27.7 78 158 287.7 768 0.968 9,874 9,876 0 0 46 

61 Q4 202 32.4 50.5 113.5 248 876 1.18 9,049 9,090 6.7 0 45 

62 Q1 191.5 24.7 76.5 135 297.5 713 1.007 7,265 7,277 2.6 0 38 

62 Q2 227.9 29.1 75 183 326 626 1.089 8,186 8,204 2.8 0 36 

62 Q3 254.5 30.4 102.5 202.5 366.2 736 0.944 9,358 9,416 5.4 0 37 

62 Q4 178.8 33.8 26.1 76 293 788 1.793 6,275 6,437 19.4 0 36 

63 Q1 250.5 44.9 73 195 316.5 1,323 1.087 8,466 8,517 5.9 0 34 

63 Q2 187.6 27.3 54.8 122 320.8 511 1.311 6,553 6,566 5.7 0 35 

63 Q3 345.7 48.7 117.5 248 470.5 1,204 1.028 11,732 11,754 2.9 0 34 

63 Q4 198.6 23.6 67 173 267 530 1.025 7,136 7,150 5.6 0 36 

64 Q1 207.8 40.6 26.5 114.5 335 657 1.881 5,147 5,195 12 0 25 

64 Q2 246.2 43.8 64 172 340 754 1.238 5,890 5,909 4.2 0 24 

64 Q3 371.7 55.2 138.8 294 543.5 864 1.012 8,548 8,549 4.3 0 23 

64 Q4 164 30.8 11.5 104 292.8 451 2.4 3,661 3,772 30.4 0 23 

65 Q1 186 33.5 38 111.5 318 754 1.575 5,887 5,952 18.8 0 32 

65 Q2 161.5 28.9 62.8 98 164.8 574 0.716 4,988 5,006 6.5 0 31 

65 Q3 143.4 25.3 48.5 105.5 157.5 614 0.873 4,141 4,159 3.4 0 29 

65 Q4 130.8 22.2 29.5 88 176.5 504 1.326 3,868 3,924 10 0 30 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 

76 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 12 Total number of quarterly doses 

The following two modified boxplots for 1956-1965 are for the departments with low potential for 

external exposure that had a large number of working quarters before and after 1961. The 

corresponding tables contain the summary statistics used to obtain the boxplots. Because of the low 

exposure potential, most of the quarters before 1961 were not monitored. However, when complete 

monitoring was initiated, nearly all doses were below 10% of the Radiation Protection Guidelines. 

Figure 21. Modified Boxplot for Beta Doses in Department 2014, 1956-1965 

77 of 81-Appendix 1 
 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

(year, 

quarter) 

Kmm1 Kmse2 

Table 5-17: Department 2014 Summary Statistics 

xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

59 Q4 NA NA NA NA NA NA NA NA NA 33.3 NA 3 

60 Q1 NA NA NA NA NA NA NA NA NA 66.7 NA 3 

61 Q1 29.9 5.4 6.6 15 22.6 698 0.918 3,181 4,365 59.6 5 146 

61 Q2 10.4 1.3 2.6 6.4 11.9 143 1.141 719 1,477 59.9 1 142 

61 Q3 14.7 1.4 5.6 10.3 17.3 148 0.842 1,818 2,058 15 1 140 

61 Q4 12.7 1.6 4.4 7.5 13.5 121 0.822 722 1,689 68.4 3 133 

62 Q1 21.6 4.9 3.8 9.3 18 1,082 1.157 4,099 5,033 38.6 2 233 

62 Q2 27.1 4.6 5.5 14.8 24.4 931 1.11 5,251 6,016 26.1 2 222 

62 Q3 22 1.6 13.2 19.1 23.5 192 0.426 1,812 4,884 77 10 222 

62 Q4 18 2.7 2 18.2 22.7 317 1.789 1,413 4,050 82.7 0 225 

63 Q1 27.6 3.6 14.1 20.3 26.1 540 0.456 2,747 6,017 79.4 6 218 

63 Q2 9.3 2 0.5 1.5 7.4 368 1.97 1,036 2,102 74.8 0 226 

63 Q3 27 1.7 17.1 20.3 27.1 291 0.343 4,340 6,453 44.8 15 239 

63 Q4 16.9 1.7 7.1 11.7 15.9 300 0.594 1,896 3,988 71.2 10 236 

64 Q1 19.8 1.1 11.8 16.1 20.3 104 0.404 1,574 4,396 76.6 12 222 

64 Q2 29.3 2 13.9 20.4 26 245 0.464 3,507 6,094 62.5 14 208 

64 Q3 24.7 1.6 12.1 20.1 31.7 219 0.712 4,727 5,236 15.6 2 212 

64 Q4 25.2 2.4 17.2 21.3 24.6 267 0.266 1,391 5,216 88.9 11 207 

65 Q1 19.3 3.3 5.7 7.8 14 678 0.672 2,224 4,400 78.5 10 228 

65 Q2 16.4 1.4 8.5 11.7 17.6 224 0.541 2,755 3,608 30.9 7 220 

65 Q3 13.9 1.4 5 8.8 13.5 245 0.736 2,030 3,002 39.8 4 216 

65 Q4 13.6 1.6 7.4 10.8 17.3 66 0.633 514 2,924 87.9 1 215 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

78 of 81-Appendix 1 
 

 

 

 

 

 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Date 

(year, 

quarter) 

Kmm1 Kmse2 

Table 5-18: Department 2018 Summary Statistics 

xq253 xq504 xq755 Xmax6 Rsdy7 Cdose8 Cdosea9 Pnd10 Nout11 N12 

60 Q4 NA NA NA NA NA NA NA NA NA 0 NA 3 

61 Q1 45.7 10.2 8.6 16.5 28.8 2,935 0.897 13,213 15,949 51 10 349 

61 Q2 40.5 8.9 4 9.6 20.4 2,583 1.202 12,468 14,216 49.6 9 351 

61 Q3 32.2 4.7 6.9 11.6 24.2 1,014 0.933 10,618 11,141 12.4 11 346 

61 Q4 25.5 7.8 3.6 8.6 16.5 2,641 1.126 6,671 8,798 60.9 3 345 

62 Q1 19.4 1.3 5.5 11.3 22.3 181 1.034 5,817 6,965 28.7 1 359 

62 Q2 30 2.2 7.8 16.9 33.3 372 1.08 9,018 10,050 23.3 2 335 

62 Q3 25.4 3 10.5 16.3 21.6 788 0.533 5,410 8,763 64.3 20 345 

62 Q4 20.1 2.1 10.4 16.2 21.1 283 0.525 2,059 6,955 90.2 7 346 

63 Q1 29.6 2.7 15.7 20.8 26.3 503 0.382 5,108 10,242 75.1 17 346 

63 Q2 22.9 3.7 2.4 8.3 21 726 1.622 5,147 7,946 75.2 1 347 

63 Q3 42 11.8 13.8 20.3 25.1 4,000 0.445 10,946 14,448 56.4 24 344 

63 Q4 20.9 2 4.8 14.2 20.6 437 1.072 4,496 7,210 61.7 4 345 

64 Q1 25.2 2.3 11.6 16.5 21.2 417 0.45 3,309 6,703 77.4 16 266 

64 Q2 40.1 8.2 13.8 20.9 26.9 1,832 0.495 7,176 10,266 61.7 15 256 

64 Q3 26.4 2.4 11.9 19.6 27.7 530 0.629 6,331 6,970 14.4 6 264 

64 Q4 26.4 3.6 7.1 14.2 26.1 277 0.963 2,828 6,679 85.8 3 253 

65 Q1 28.3 3.8 7.1 13.5 20.1 539 0.771 4,396 6,820 71.4 12 241 

65 Q2 22.6 1.9 7.2 13.2 23.9 198 0.884 4,374 5,040 24.2 2 223 

65 Q3 27.8 4.8 5.7 10.5 18.7 614 0.882 5,308 6,227 34.8 9 224 

65 Q4 17 1.7 5.5 14.3 20.8 205 0.981 1,295 3,740 78.6 1 220 

Notes: 

1 K-M estimate of the mean for the quarter 

2 K-M estimate of the standard error of the K-M mean 

3 25th quantile 4 50th quantile; estimate of the GM 

5 75th quantile 

6 Maximum dose in quarter 

7 [log(xq75) – log (xq25)] / 1.35— estimate of log (GSD) 

8 Cumulative dose 

9 n*kmm—“adjusted” cumulative dose

10 Percent non-detects 11 Number of positive outliers 12 Total number of quarterly doses 

79 of 81-Appendix 1 
Monitoring Data Sufficiency Appendix 1 for SEC-00028 

Figure 22. Modified Boxplot for Beta Doses in Department 2018, 1956-1965 

80 of 81-Appendix 1 
 

 

Monitoring Data Sufficiency Appendix 1 for SEC-00028 

6.0 References 

ORAUT-OTIB-0013, Technical Information Bulletin: Individual Dose Adjustment Procedure for Y12 Dose Reconstruction; September 9, 2004; SRDB Ref ID: 19431 

ORAUT-OTIB-0029, Technical Information Bulletin 0029, Internal Dosimetry Coworker Data for 

Y-12; April 5, 2005; SRDB Ref ID: 19452 

ORAUT-OTIB-0047, Rev. 00, External Radiation Monitoring at the Y-12 Facility During the 1948-

1949 Period; September 20, 2005; SRDB Ref ID: 19462 

ORAUT-TKBS-0014-2 Rev. 00, Technical Basis Document for the Y-12 National Security Complex 

-Site Description, Rev. 00; SRDB Ref ID: 20196 

ORAUT-TKBS-0014-6, Rev. 00, Technical Basis Document for the Y-12 National Security Complex 

– Occupational External Dosimetry, Rev.00; SRDB Ref ID: 20208 

ORAUT-TKBS-0014-1, Rev. 00, Technical Basis Document for the Y-12 National Security Complex 

– Y-12 Site Profile, Rev.00; SRDB Ref ID: 20193 

ORAUT-TKBS-0014-3, Rev. 00, Technical Basis Document for the Y-12 National Security Complex 

– Occupational Medical Dose, Rev. 00; SRDB Ref ID: 20200 

ORAUT-TKBS-0014-5, Rev. 01-A, Technical Basis Document for the Y-12 National Security 

Complex – Occupational Internal Dose, Rev. 01-A; SRDB Ref ID: 20206 

ORAU Technical Report 2004-0888, Historical Evaluation of the Film Badge Dosimetry Program 

at the Y-12 Facility in Oak Ridge, Tennessee, Part 1 – Gamma Radiation; 2004; SRDB Ref ID: 

14995 

ORAU Technical Report 2004-1406, Historical Evaluation of the Film Badge Dosimetry Program 

at the Y-12 Facility in Oak Ridge, Tennessee, Part 2 – Neutron Radiation; 2004; SRDB Ref ID: 

16843 

ORAUT-PROC-0042, Accounting for Incomplete Personal Monitoring Data on Penetrating 

Gamma-Ray Doses to Workers in Radiation Areas at the Y-12 Plant Prior to 1961; August 9, 2004; 

SRDB Ref ID: 20212 

McLendon, 1963, Y-12 Radiation Safety Manual, Y-12 Plant: Oak Ridge, Tennessee; 1963; SRDB 

Ref ID:8541 

81 of 81-Appendix 1